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Abstract 
This study aims to address how easily an individual with no prior inhaler experience can learn to use a dry powder 
inhaler (DPI) through video education. This is a comparative study of four DPIs (Diskus, Easyhaler, Ellipta and 
Turbuhaler). Different properties affecting ease of use, patient preference as well as educational videos as a method 
of providing inhaler instructions were investigated.  The study used a triangular methodology. The sample con-
sisted of 31 individuals (24-35 years). All participants were considered inhaler naïve. After watching the video 
education material for a particular inhaler the participants’ demonstrated the use of it. Educational videos for all 
four inhalers were watched and use of all placebo inhalers was demonstrated in a random order. These demonstra-
tions were videotaped. The demonstrations were thereafter checked against a predefined checklist and all mistakes 
were recorded.  
 
Only 33 % of inhaler demonstrations were completed without the participants making any mistakes that could 
compromise the efficacy of the inhaled medication in a real-life situation. The frequency of error varied greatly 
between different types of inhalers. Ellipta proved to be most often used correctly with 55 % demonstrating use 
without making any mistakes. This was closely followed by Diskus for which 48 % demonstrated correct use. The 
difference between the average error frequency for Ellipta and Diskus was statistically insignificant. With 
Easyhaler 19 % percent of participants were able to demonstrate correct use, the corresponding percentage for 
Turbuhaler was 16 %. When comparing participants’ demonstrations for Easyhaler and Turbuhaler, the difference 
in average error frequency between the devices were not statistically significant. The average frequency of error 
was lower when using Ellipta in comparison to Easyhaler and Turbuhaler (statistically significant). The same in-
dications were found when comparing average frequency of error for Diskus, to those for Easyhaler and Turbuha-
ler.  Comparing the participants self-reported correct use against the actual numbers it is clear that participants 
often thought they were using the inhaler correctly when they in fact were not. When asked to rank the inhalers 
from most preferred to least preferred, Ellipta emerged as a favorite. Turbuhaler received the second highest scores, 
Diskus the third and Easyhaler was least preferred. However, only the difference between preference scores for 
Ellipta and Easyhaler was deemed statistically significant. 
 
The high frequency of error suggests that even though participants generally considered the inhalers intuitive and 
easy to use, they would have required more comprehensive inhaler education in order to achieve correct inhaler 
technique. Further, the results indicate that video demonstrations are not ideal for providing inhaler education for 
first time inhalers users. The most prominent problem with video education is that it provides no feedback to the 
user regarding their inhaler technique. This may present real problems as the results of this study show that partic-
ipants tended to overestimate their own inhaler technique. Patient education plays a central role in asthma care and 
needs to be given proper attention even though the inhalers might be considered intuitive and easy to operate. 
Interesting areas for future research include investigating interactive learning videos as a way of improving video 
education on inhaler technique.  
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Referat  
Syftet med denna studie är att undersöka hur lätt en individ utan tidigare erfarenhet av inhalatorer kan lära sig att 
använda en pulverinhalator (DPI) med hjälp av videoinstruktioner. Studien jämför fyra inhalatorer (Diskus, Easy-
haler, Ellipta och Turbuhaler). I studien undersöks olika egenskaper hos inhalatorer som påverkar användarvänlig-
heten och patientpreferensen. Samtidigt undersöks utbildningsvideon som ett sätt att erbjuda användarinstruktioner 
för inhalatorer. Studien tillämpade en triangulär metod. Samplet bestod av 31 individer (24-35 år). Alla deltagare 
saknade tidigare erfarenhet av inhalatorer. Deltagarna visades en instruktionsvideo, varefter de uppvisade använd-
ningen av den inhalator vars instruktionsvideo just visats.  Deltagarna tittade på utbildningsvideon för alla fyra 
inhalatorer och uppvisade användningen av placeboinhalatorerna i slumpmässig ordning. Deltagarnas inhalatoran-
vändning videofilmades. Därefter kontrollerades deltagarnas inhalatorteknik mot en på förhand definierad lista och 
alla fel registrerades.  
 
Endast 33 % av inhalationsuppvisningarna genomfördes utan några misstag som kunnat påverka effekten av det 
inhalerade läkemedlet i en verklig situation. Felfrekvensen varierade kraftigt mellan olika inhalatortyper. Ellipta 
var den inhalator som oftast användes rätt och 55 % av uppvisandena genomfördes utan fel. Därefter följde Diskus 
för vilken 48 % av deltagarna visade korrekt inhalationsteknik. Skillnaden mellan de genomsnittliga felfrekven-
serna för Ellipta och Diskus var inte statistiskt signifikanta. Vid uppvisning av inhalationsteknik för Easyhaler 
genomfördes 19 % av uppvisningarna utan fel. För Turbuhaler var den motsvarande siffran 16 %. Skillnaden mellan 
de genomsnittliga felfrekvenserna för Easyhaler och Turbuhaler var inte statistiskt signifikanta. Den genomsnittliga 
felfrekvensen var lägre vid användning av Ellipta i jämförelse med Easyhaler och Turbuhaler (statistiskt signifi-
kant). Samma resultat erhölls då man jämförde den genomsnittliga felfrekvensen för Diskus med de genomsnittliga 
felfrekvenserna för Easyhaler och Turbuhaler. Då deltagarnas självrapporterade användning jämfördes med de 
verkliga resultaten framkom det tydligt att deltagarna ofta trodde att de använt inhalatorn korrekt då de i verklig-
heten hade gjort ett eller flera fel. När deltagarna ombads rangordna inhalatorerna från mest omtyckt till minst 
omtyckt framkom Ellipta som favorit. Turbuhaler fick de näst bästa poängen, Diskus kom in som trea och Easyhaler 
framkom som minst omtyckt.  Dock var endast skillnaden i preferens mellan Ellipta och Easyhaler statistiskt sig-
nifikant.  
 
Den höga felfrekvensen antyder att även om deltagarna i allmänhet tyckte inhalatorerna var intuitiva och lätta att 
använda skulle de ha behövt mer omfattande träning för att uppnå korrekt inhalationsteknik. Vidare tyder resultaten 
på att videodemonstrationer inte är ideala för att ge instruktioner i inhalatorteknik då inhalatorn används för första 
gången. Ett stort problem med videoinstruktioner är att användaren inte får någon feedback på den egna inhalat-
ionstekniken. Detta kan innebära problem eftersom resultaten från denna studie visat att deltagare ofta överskattade 
den egna inhalationstekniken. Patientutbildning spelar en viktig roll i behandlingen av astma och måste uppmärk-
sammas även om inhalatorer kan anses vara intuitiva och lätta att använda. Framtida forskning kunde undersöka 
hur interaktiva utbildningsvideon skulle kunna användas för att förbättra utbildningsvideon om inhalationsteknik.  
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Abbreviation Full name 
DPI Dry powder inhaler 
LABA Long-acting beta-2-agonists 
SABA Short-acting beta-2-agonists 
BDP Beclomethasone diproprionate 
FEV1  Forced expiratory volume in 1 s 
FVC Forced vital capacity 
FPF Fine particle fracture 
FPM Fine particle mass 
TED Total emitted dose 
THL The National Institute for Health and Welfare 
GSK GlaxoSmithKline 
AZ Astra Zeneca 
FPD Fine particle dose 
API Active pharmaceutical ingredient 
CFD Computational fluid dynamics 
PIF Peak inspiratory flow 
PEF Peak expiratory flow 
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1. Introduction 
 
In recent years there have been many studies investigating incorrect use of asthma inhaler 
and the effect this has on asthma therapy and the patients’ health. Before market entry 
inhalers undergo rigorous testing in randomized controlled trials (Haughney et al. 2010).  
These trials generally exclude patients who exhibit suboptimal inhaler technique. This 
may create a distorted perception of inhaler use and handling errors patients face in eve-
ryday life. Inhaler errors among asthma patients are common and it has been stated that a 
majority of asthma patients make mistakes while using their inhalers (Onyedum et al. 
2014). The frequency of error varies between different studies but it is estimated that 
between 50 – 94 % of asthma and COPD patients make at least one mistake when using 
their inhalers (Crompton et al. 2006; Lavorini et al. 2008). The incidence of errors during 
inhaler use is highly dependent on which inhaler is used and the frequency of error may 
therefore vary greatly between different studies (Crompton et al. 2008).  
 
Improper inhaler technique can lead to decreased efficacy, if it results in reduced dispo-
sition of the active substance in the lungs (Price et al. 2012). As such, inhaler technique 
plays a vital role in successful treatment of asthmatic patients. Demonstrating correct in-
haler technique has not only been proved to be hard for patients, but also health care 
professionals have been found to struggle with this issue. A study by Self et al. (2007) 
among others showed that a majority of health care professionals displayed lack of skill 
when asked to demonstrate the correct use of various asthma inhalers. This is an alarming 
statistic as health care professionals usually are the ones instructing patients on how to 
use their inhalers correctly. Poor inhaler technique has been associated with increased 
asthmatic symptoms, higher costs and reduced effect on lung function (Price et al. 2012). 
It has also been suggested that it could lead to patients experiencing more side effects and 
less adherence to therapy.  
 
The costs associated with asthma are substantial from both a health care and societal point 
of view. In Finland the overall costs of asthma are estimated to be roughly 240 million 
euro (Reissel et al. 2010). Research seems to indicate that costs increase significantly with 
increasing asthma severity (Price et al. 2012; Godard et al. 2002). The American TENOR 
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study concluded that the health care expenditure for an uncontrolled asthma patient was 
as much as twice as high as the health expenditure for a patient with controlled asthma 
(Sullivan 2005). It appears that decreasing the amount of inhaler errors and subsequently 
increasing the degree of adherence among patients could help to contribute to a higher 
quality of life among some patients through factors such as decreased asthmatic symp-
toms and higher lung function. Furthermore this could be a step towards reducing the 
asthma related costs from both a healthcare and societal point of view. With the cost 
pressure in pharmacies and hospitals increasing, time allocation changing and the demon-
strated lack of skill among health care professionals taken into consideration an educa-
tional videotape can be considered cost efficient way of providing easily accessible and 
standardized inhaler education to asthma patients. The foundation for this thesis is the 
idea that easily accessible education in combination with a patient friendly and intuitive 
inhaler device that leaves little room for mistakes could be a step towards reduced inhaler 
error frequency and increased adherence among asthma patients.  
 
The purpose of this study is to examine how a naïve subject without inhaler experience 
finds the use of an inhaler after receiving a short video education. The study measures 
how frequent inhaler errors are for each inhaler type after this type of demonstration. This 
is measured through videotaped inhaler demonstrations where the participants’ inhaler 
performance is scored according to a predetermined checklist.  The study evaluates the 
user friendliness of the most frequently sold dry powder inhalers in Finland, as well as 
the most recent newcomer to the Finnish market. As another dimension for measuring 
user friendliness the participants filled in forms evaluating different characteristics of the 
inhalers and educational material used in this study. Research by Small et al. (2011) sug-
gests that the level of satisfaction patients have with their inhaler device is observed to 
have a positive influence on the treatment goals for asthma through its association with 
improved adherence. Based on this, the study aims to address the participants’ personal 
preferences and perception of the inhalers they try. Finally the study aims to evaluate 
videos as a method of providing inhaler education with the purpose of teaching individu-
als how to correctly use an asthma inhaler. As this is a comparative study of four inhalers, 
the results for each aspect of this study will be compared between the inhalers used by 
the participants.  
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2. Definitions 
 
The terms compliance, concordance and adherence are commonly used to describe the 
patient’s medicine-taking and how they follow treatment instructions (Horne 2005). Con-
cordance, adherence and compliance are sometimes used interchangeably (McDonald et 
al. 2002). There are, however, a subtle differences between the terms and they should not 
be used synonymously (Mäkelä et al. 2013; Horne 2005; Bell et al. 2007). This study will 
mainly focus on adherence sometimes touching upon compliance.  
 
Compliance and adherence are terms that both concern the medicine-taking behavior of 
the patient (Bell et al. 2007). Compliance was for long the most widely used term. Com-
pliance is defined as “the extent to which the patient’s behavior matches the prescriber’s 
recommendations” (Haynes et al. 1979).  Adherence is defined as the extent to which a 
patient's activities and behavior, in terms of taking medication, following a diet, adjusting 
habits or executing a lifestyle, corresponds to the medical or health advice given to them 
(Lamas et al. 1992; Haynes et al. 1979).  The term compliance generally infers a lack of 
patient involvement and adherence is therefore generally considered the preferred term 
(Mäkelä et al. 2013). 
 
Non-adherence refers to a state in which the patient adhered from the medical or health 
advice described to them. Non-adherence can be separated into several categories. There 
are three common categories of non-adherence to therapy: overuse, underuse and im-
proper use (Restrepo et al. 2008). This study will focus on adherence that stems from 
improper use. Additionally one can distinguish between intentional non-adherence and 
unintentional non-adherence (Wroe 2002). Intentional non-adherence refers to a situation 
in which the patient misses/alters doses to suit their needs, whereas unintentional non-
adherence refers to a situation where the patient for example forgets to take their medica-
tion or unintentionally adheres from the medical or health advice prescribed to them. 
 
Critical inhalation errors are defined as all errors in the use or handling of the inhaler 
that is expected to significantly impair the delivery of a sufficient amount of medication 
(Price et al. 2013). Critical errors they have been documented for all types of inhalers. 
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Dry powder inhalers (DPIs) are devices that deliver dry powder formulations of an active 
drug for local or systemic effect via the pulmonary route (Islama & Gladki 2008). Multi-
dose DPI devices are defined as DPIs that contain more than one dose (Chrystyn 2007). 
Multi-dose reservoir devices are inhaler devices that release individual doses with each 
actuation from a bulk supply of the pharmaceutical held within the inhaler device 
(Chrystyn 2007). 
 
Fine particle fraction is defined as the fine particle dose divided by the dose that is actu-
ally delivered (Savolainen 2010). The fine particle dose is defined as the dose, which is 
delivered in particles that are smaller than 5 μm in diameter (Savolainen 2013). 
 
The term aerosolization refers to the dispersal of i.e. a medicine in the form of an aerosol 
(Merriam Webster 2015). Inspiratory flow rate, which is expressed in L/min, is defined 
as the maximum instantaneous airflow that a person can achieve during forced inspira-
tion.  
 
 
3.  Structure and delimitations  
 
The remainder of this thesis is divided into four sections. First some background infor-
mation and previous research is reviewed and presented with the intention of forming a 
base and initial framework for the study. The literature review examines previous re-
search of asthma as a disease, the effects of in-adherence, the most common mistakes for 
inhalers, patient preference, inhaler education and ease of use.  Thereafter general specif-
ics of dry powder inhalers, factors related to inhaler handling, their design and are pre-
sented. Finally the four inhalers that are a part of this study are presented in more detail.  
Next, the research method applied to this study is introduced and discussed. The chosen 
methods are explained and clarified. The approach of the study is discussed and the re-
search design is presented. Thereafter the data collection process is presented and the 
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methods for data collection are described. Finally the reliability and validity of the study 
and the chosen method are discussed from a critical perspective. 
In the sixth chapter the empirical findings are presented and analyzed. Finally the findings 
of this study are discussed based on the theoretical framework. A conclusion to the study, 
including applied recommendations for future asthma inhalers and inhaler education is 
presented. An overview of the structure and process of this thesis is presented in Figure 
1. 
 
Figure 1: Structure of the study.  
 
This thesis will be limited to inhalers used in the treatment of asthma. There are a great 
number of asthma inhalers available on the Finnish market. In this study I will focus 
solely on dry powder inhalers. More specifically the study will include the three most 
frequently sold dry powder inhalers in Finland, as well as the most recent newcomer in 
the category of dry powder inhalers on the Finnish market. The inhalers that will be a part 
of this study are Diskus (GSK), Ellipta (GSK), Easyhaler (Orion) and Turbuhaler (Astra 
Zeneca). Some of the inhalers used in this study may also be prescribed for the treatment 
of COPD, but since they are primarily classified as asthma inhalers, the study will focus 
on this point of view. 
 
When discussing adherence this study will solely focus on unintentional adherence in the 
form of incorrect inhaler use. All other forms of non-adherence will be excluded from 
this study. There are several forms of inhaler education. For the purpose of this thesis the 
Problem 
background 
and purpose
Previous 
research and 
theory
Methodology
Results and  
analysis
Conclusions
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focus will be solely on educational videos. Other forms of inhaler education, such as face 
to face instructions and interactions will be excluded. 
 
 
4. Literature review  
 
4.1 An overview of asthma  
 
Asthma is a chronic disease that affects 235-300 million individuals worldwide (Accordini et 
al. 2008; Masoli et al. 2004). Chronic respiratory diseases, such as asthma and chronic ob-
structive pulmonary disease (COPD) signify up to 5 % of the total disease burden and 8.3 % 
of chronic disease burden worldwide and globally asthma is considered to be a central cause 
of mortality, morbidity and economic burden (WHO 2013). 
 
In Finland 7-10 % of the population suffers from asthma. Additionally it is estimated that 
approximately 5 % of the population occasionally suffer from asthma-like symptoms 
(Haahtela 2013). Asthma is characterized by symptoms such as repeated attacks of 
breathlessness and wheezing (WHO 2013). The severity of asthmatic symptoms and their 
rate of recurrence vary among patients. Even though the root causes of asthma are not 
fully understood to date, some risk factors have been identified. These include a combi-
nation of genetic disposition and exposure to inhaled substances and particles that may 
provoke allergic reactions or cause irritation in the airways. At the time of an asthma 
attack the lining of the bronchial tube start swelling (WHO 2013). This causes the airways 
to narrow, reducing the airflow to the lungs.  
 
Asthma has become a major public health problem, especially among inner city popula-
tions (Moormarn et al. 2007; Gupta et al. 2006; Wisnivesky et al. 2005). Urbanization 
has been linked to the increasing incidence of asthma, the precise nature of this relation-
ship, however, remains unclear (WHO 2013). Asthma has a comparatively low rate of 
fatality in comparison to other chronic diseases, such as COPD. Asthma is nowadays 
rarely fatal in developed countries (Price et al. 2013).  The majority of asthma-related 
deaths today take place in countries with low- and lower-middle income (WHO 2013).  
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Asthma symptoms are periodic and patients can experience long symptom-free periods. 
The treatments available for asthma include effective controller and reliever therapy. 
 
Asthma is most often treated with inhaled therapies (Svedsater et al. 2013). Asthma treat-
ment through inhaled therapies facilitate high lung disposition of the drug with minimized 
systemic bioavailability. This significantly reduces the chance of possible systemic drug 
interactions (Lavorini et al. 2008).  The primary target of asthma medication is to treat 
the inflammation that is occurring on the mucous membrane (Käypähoito 2012).  
 
The main objective of contemporary treatment guidelines for asthma is to attain clinical 
control (Accordini et al. 2008). This encompasses a combination of symptom control and 
maintenance of normal activity levels for the treated patient (Accordini et al. 2008). De-
spite of the fact that asthma treatment guidelines have been both extensively published 
and are easily available, there appears to be a significant gap between the aims of treat-
ment and the actual level of asthma control among patients (Gillissen 2004). Incorrect 
inhaler use has been suggested as a contributing factor to this problem. This study aims 
to address this issue by gaining a deeper understanding of the frequency of error for com-
mon DPIs on the Finnish market. 
 
The clinical picture of asthma as a disease places clear requirements on the inhalers used 
for treatment. One of these requirements is user-friendliness during an asthma attack as 
well as during the long time treatment of the disease (Lavorini et al. 2008). Price et al. 
(2012) states that one of the factors that signifies an ideal inhaler is that it is easy to both 
teach and learn how to use. Other important properties of asthma inhalers that have been 
considered key factors are minimal requirements for cooperation and coordination, min-
imal cleaning and high patient preference (Lavorini et al. 2008). Inhalers play an im-
portant part in achieving asthma control, and therefore the needs set up by the disease 
need to be taken into careful consideration when developing inhalers. The properties of 
asthma inhalers that affect patients will discussed further on in this thesis. 
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4.2 The effects of in-adherence 
 
Despite evidence demonstrating clear therapeutic benefit for adhering to the prescribed 
therapy many patients fail to take their medicines as advised (Rolnick et al. 2013). Ad-
herence seems to be an important issue in the treatment of most chronic diseases and it is 
estimated that approximately 50 % of individuals suffering from chronic diseases in de-
veloped countries adheres to prescribed therapy (Price et al. 2013). Asthma is no excep-
tion in the statistics and it is estimated that nearly 50 % of patients do not take their med-
ication as prescribed.  
 
A study among Korean asthma patients found a considerable discrepancy between pre-
scription refill adherence and self-reported adherence to therapy. The self-reported adher-
ence to therapy was reported to be much higher than the actual adherence. In this study 
the adherence was measured through the refill of asthma medication prescriptions for 
patients (Bae et al. 2009). 
 
Non-adherence to therapy increases the risk that patients will not receive the intended 
benefits of the therapy and the risk of developing secondary consequences of their origi-
nal condition (Rolnick et al. 2013). Suboptimal adherence to treatment also negatively 
affects patients by contributing to an impaired quality of life (Price et al. 2013; Barnes et 
al. 1996; Bahadori et al 2009; Kong et al. 2005). Furthermore, research seems to suggest 
that non-adherence in the long run is likely to lead to higher overall health care costs 
(Roebuck et al. 2011). The increase in health care expenditures stem from accumulated 
costs of wasted medication, emergency care and hospitalizations that could have been 
avoided through proper control of the disease (Price et al. 2013a; Barnes et al. 1996; Ba-
hadori et al. 2009; George et al. 2005). 
  
The costs associated with asthma are substantial from both a heath care and societal per-
spective. In Finland the overall costs of asthma are estimated to be approximately 240 
million euros (Reissel et al. 2010). Research seems to indicate that costs increase signifi-
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cantly with increasing asthma severity (Price et al. 2012; Godard et al. 2002). An Amer-
ican study concluded that the health care expenditure for an uncontrolled asthma patient 
is as much as twice as high as the health expenditure for a patient with controlled asthma 
(Sullivan 2005).  It is estimated that out of an assessed $25 billion spent on asthma inhal-
ers per year, $5–7 billion is wasted due to inhaler misuse (Fink & Rubin 2005). 
 
In addition to the in-adherence that arises from incorrect inhaler use there are many other 
root causes for non-adherence in the treatment of asthma (GINA-report 2014). The global 
initiative for asthma reports that around 50 % of asthma patients do not take their con-
troller medication as prescribed. Reasons behind unintentional non-adherence in asthma 
care include forgetfulness, costs and misunderstandings whereas the underlying reasons 
for intentional non-adherence may stem from factors such as not perceiving the need for 
treatment, fear of side-effects, cultural issues or cost (GINA-report 2014).  
 
Inadequate use of inhaler devices has been recognized as one of the leading reasons for 
not achieving asthma control (Melani et al. 2011).  The frequency of misuse is dependent 
on the type of inhaler device (GINA-report 2014). Properties of the inhalers used for 
treatment have been shown to affect patient adherence (Hoppentocht et al. 2014). Robust-
ness, ease of handling and convenience are fundamental inhaler properties for achieving 
correct inhaler use and therapy adherence among patients (Hoppentocht et al. 2014). Non-
adherence that stems from improper inhaler technique will be described in further detail 
in the next chapter.  
 
4.3 Defining the most common inhaler errors 
 
Inhaler use is affected by a number of diverse factors, such as, the device itself, the patient 
or consumer as well as health care professionals (Price et al. 2012). All inhalers require 
that the patient exhibit a certain level of physical skill, dexterity, manipulation, hand-
strength and lung capacity in order to achieve the intended therapeutic effect.  Correct 
inhaler technique plays a crucial part in achieving this. This section will focus on inhala-
tion errors that may compromise the therapeutic benefits for the patient. These errors are 
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called critical errors. Critical errors are exhibited when a patient performs an error, dis-
plays flawed technique or lacks knowledge of the usage/ maintenance of the inhaler de-
vice that is likely to significantly impair the delivery of adequate medication on all occa-
sions of drug administration.  
 
According to comprehensive literature review regarding inhalation technique the most 
frequently occurring error among patients using DPIs, was not remembering to exhale 
before using their devices (Lavorini et al. 2008). This error was made by 12–77 % par-
ticipants depending on the type of inhaler used. The second most common handling error 
was failure to hold breath after inhalation; this mistake was made by 0–73 % depending 
on the inhaler.  In addition to differences between inhaler types the large range can also 
be attributed to the fact that different studies used different methods of assessment.  
 
Another common handling error observed in the review article was failure to forcefully 
and deeply inhale through the device, a mistake made by 0–48 %, depending on inhaler 
type and study. The great range can also be explained by the fact that different types of 
inhalers present different requirements for forceful inhalation. Some inhalers can achieve 
sufficient drug delivery with a smaller inspiratory flow rate whereas other inhalers re-
quire much more forceful inhalation in order to achieve optimal drug delivery. Other 
common inhalation errors included incorrect dose metering (1–46 % of users), incorrect 
rotation sequence during loading (i.e. rotation of grip until ‘click’ is heard), a mistake 
made by 0–45 %); incorrect inhaler position (0–44 % of participants); failure to breathe 
out slowly after inhalation (2–43 %); and finally, incorrect mouthpiece position (i.e. not 
positioning the mouth piece correctly between the lips, 0–35 %). The large range for the 
results can be attributed to the factor such as varying frequency of error for different 
types of inhaler as well as different methods of assessment used in different studies. (La-
vorini et al. 2008) 
 
In addition to the review by Lavorini et al. (2008) other research seems to support that 
some errors appear to occur more frequently than others. Research by Melani et al. (2004) 
and Khassawneh et al. (2008) investigated error frequencies for Aerolizer, Turbuhaler and 
Diskus, and van der Palen’s research group focused on the error frequency for Turbuhaler. 
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In all the mentioned research the patients’ inhalation technique was determined based on 
predetermined steps critical in the patients’ inhalation technique. The results were given 
points and gathered in a table. All participants in these studies were patients who suffered 
from asthma and had prior inhaler experience. Table 1 lists the most common mistakes 
made by participants in three different studies regarding inhaler technique for DPIs’. 
 
The errors in Table 1 can all contribute to decreasing the therapeutic effect of the inhalers 
used. Holding the inhaler in the right position is especially important for reservoir inhalers 
such as Easyhaler and Turbuhaler. It is essential that they are held in an upright position 
as the dosing mechanism of the inhalers depends on gravity to fill the dose metering cup 
(Chrystyn 2007). As such, incorrect inhaler positioning can lead to the patient not receiv-
ing the correct dose. As can be seen in Table 1, this error occurred especially for the 
Turbuhaler, with 37 % of participants using Turbuhaler in the study by Khassawi et al. 
(2008) and 31 % of participants in a study by van der Palen et al. (1995) making this 
mistake. Errors related to the breathing technique such as exhaling before inhalation, 
holding breath after inhalation and not inhaling forcefully enough during the inhalation 
are all factors that may affect the drug delivery to the lungs (Chrystyn 2007; Lavorini 
2013).  
 
Exhalation into a DPI is accompanied by several problems (Basheti et al. 2005). First and 
foremost exhaled gas can blow the powder out of the chamber, making it unobtainable 
for inhalation. Secondly exhaled gas is highly humid; this may cause the carrier and/or 
drug to cake or agglomerate, reducing its ability to break up into individual respirable 
particles during inspiration. 
 
The final critical error that can be identified in Table 1 is related to the actual loading of 
the device. Loading the device is a step that assures that the medication is divided into 
doses and ready to be delivered to the lungs upon inhalation. If this phase is done incor-
rectly, there is a risk that the parts of the medication, or in some cases even all of it, is not 
delivered to the lungs and the therapeutic effect is not fully achieved (Chrystyn 2007). 
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Table 1: The table shows the most common mistakes made by the subjects' during use of dry 
powder inhalers (%). The error of frequency represents the percentage of participants that made 
the specified errors in each study.   
Error type 
Error frequency 
in study A 
(n1=32) 
Error frequency 
in study B 
(n1=523, n2=450 ) 
Error frequency 
in study C 
(n1=146, n2=103) 
The inhaler is not held in 
the correct position 
31 % 
27.7 %1/  
not measured 2 
25.3 % 1/ 
not measured 2 
Insufficient emptying of 
the lungs before inhala-
tion 
66 % 
24.3 %1/ 
24.4%2 
- 
Insufficient holding of 
breath 
41 % 
47.1 %1/ 
52.9 %2 
- 
Exhalation into the mouth 
piece after the inhalation 
16 % 
21.7 %1/ 
 not measured 2 
- 
Inhalation is not strong 
enough 
6 % 
16.6 %1/ 
21.7 %2 
13.7  %1/ 
3.9 %2 
Loading the device - 
8.1 %1/ 
5.9 %2 
24  %1/ 
not measured2 
n1=Number of patients using Turbuhaler, n2= number of patients using Diskus. 
Source: A=van der Palen et al. (1995), B=Melani et al. (2004), C=Khassawneh et al. (2008) 
 
 
4.4 Ease of use 
 
The most essential criteria to consider when selecting inhalers for patients is ease of use. 
No matter how exceptional pharmaceutical performance a device has displayed in terms 
of drug output it will be rendered ineffective, if the device is not used properly. Some 
research has found ease of use during an asthma attack to be the most important features 
of an ideal inhaler when patients were asked (Serra-Battles et al. 2002). Chrystyn (2007) 
argues three main points that affect the ease of use of an inhaler device. These are: the 
amount of steps needed in order to actuate the device, low requirements on inhaler train-
ing and the amount of manual dexterity needed in order to operate the device. In addition 
to ease of use, patient satisfaction and the patients’ abilities such as their lung capacity 
are important factors that influence the use of the inhaler.  
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The characteristics and needs of patients who use inhalers are often of such nature that 
simplicity of operation is of great importance (Serra-Battles et al. 2002). A study as-
sessing the inhalation technique of patients their prescribed DPI or pMDI found that 
nearly 90 % of patients made at least one mistake in their inhalation technique (van 
Beerendonk 1998). This research, among others, highlights the importance of providing 
training for asthma patients with the goal of teaching them to use their DPI correctly. 
Research has shown that effective training increases the patients’ ability to use their in-
haler properly (Serre-Batles et al. 2002; Branco Ferreira et al. 1999). 
 
Much of the research available on inhaler technique has been done under clinical condi-
tions and clinical studies often require participants to display good inhaler technique as a 
prerequisite for participation in the study (Chrystyn 2007). Consequently, real-life studies 
may be more relevant when evaluation the ease of use of DPIs. When designing an in-
haler, it is essential to maximize the simplicity of use for patients in order decrease the 
possibility for errors. Well-documented comparisons between devices are few, although 
some data is available. Another problem arises through the fact that many of the available 
studies have been sponsored by pharmaceutical companies. The results of the studies may 
therefore have to be examined critically. 
 
Due to the fact that Ellipta is a newcomer to the market very few articles are available 
regarding its ease of use. The few studies available on Ellipta´s ease of use indicate that 
the inhaler has been perceived to be easy to handle by patients and inhaler naïve subjects 
(Svedsater et al. 2013; Svedsater et al.  2014; Komase et al. 2014).  The ease of use in 
asthma patients is most clearly found in an observation from week four of the clinical 
trials for Ellipta (Svedsater et al. 2014). Participants were asked to fill in a questionnaire 
regarding the ease of use for the inhaler. A total of 1 050 people participated in the trials, 
and 94 % of these people completed the questionnaire regarding ease of use. Out of the 
respondents 65 % stated that the inhaler was very easy to use, and 94 % of respondents 
reported that it was either easy or very easy to use. Merely 1 % of the respondents ex-
pressed had been difficult or very difficult to use. It is important to note that these are 
self-reported statements by the users from a clinical trial. This may distort the answers in 
comparison to third party, real life observations. 
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The perception of Ellipta’s ease of use was supported by two comparative studies in in-
haler naïve individuals. The first compared the Breezehaler to the Ellipta and Ellipta was 
preferred based on its ease-of-use features (Komase et al. 2014). Furthermore, it was as-
sociated with fewer handling errors. The second study assessed the handling of Ellipta in 
comparison to the Diskus and Turbuhaler (Sharma et al. 2014). The study showed that an 
overwhelming majority of users were able to use the Ellipta correctly on their first attempt 
after reading a leaflet. When the Diskus was demonstrated for the first time 38.2 % of 
users exhibited one or more mistakes, and for the Turbuhaler 83 % exhibited one or more 
mistakes upon inhalation. This study was sponsored by GSK. 
 
Many studies have tried to evaluate the ease of use of different inhalers and highlighted 
the incorrect use of different devices (Chrystyn 2007). Since Turbuhaler and Diskus ap-
pear to be among the most widely used DPI’s, it is only natural that there would be a large 
number of studies available, comparing these two inhalers. Most available studies seem 
to indicate that fewer mistakes where exhibited when using Diskus in comparison to the 
Turbuhaler (Clay et al. 1994; Backman et al. 2001; Arossa et al. 1998; van der Palen et 
al. 1998). Many of these studies suggest that the difference in errors among the two in-
halers was partially or entirely caused by not loading the Turbuhaler accurately (Backman 
et al. 2001; Arossa et al.1998; van der Palen et al. 1998). The frequency of error varies 
greatly between studies. A clinical study by Clay (1994) found that 74 % of patients were 
able to use the Diskus correctly after a single demonstration in comparison with just 32 
% of patients who were able to use the Turbuhaler (Clay 1994). After two training ses-
sions 99 % were able to use the Diskus in comparison with 88 % for the Turbuhaler. In 
contrast, a randomized crossover comparison of Diskus and Turbuhaler with regards to 
patient ease of use found that 92 % of participants made no essential inhalation maneuver 
errors when using the Diskus in comparison with 74 % success rate for the Turbuhaler. 
The difference can be attributed to the fact that different studies used different methods 
of assessment as well as other differences in the methodology. 
 
Comparisons of Easyhaler’s ease of use to the other inhalers in this study were quite 
scarce. One study, comparing the inhalation technique for of seven different dry powder 
inhalers, including Diskus and Easyhaler was, however, found. The study included 72 
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patients suffering from either asthma or COPD. The lowest level of critical handling er-
rors was observed for the Diskus, the highest numbers were observed for the Easyhaler 
as well as the Jethaler. The participants of the study all inhaled two times with each in-
haler. The first inhalation occurred after reading the device leaflet, and the second after 
the handling of the device was carefully explained by the investigator. When using the 
Diskus, 25 % of participants displayed errors during the first inhalation demonstration 
and 13.9 % during the second one. The corresponding numbers for the Easyhaler was 
72.2 % for the first inhalation and 47.2 % for the second one. Device handling for all 
inhalers improved after instruction was given by the investigator (Schulte et al. 2008). 
 
Finally one study comparing three of the four inhalers used in this study was found. This 
study compared the Diskus, Easyhaler and Turbuhaler. The results of this study were also 
interesting due to the fact that they results differed from the previously mentioned com-
parisons of Diskus and Turbuhaler, as well as Diskus and Easyhaler. The study was a 4 
week, phase four, randomized multicenter parallel group trial, comparing the acceptabil-
ity and correct use amongst 326 inhaler naive asthmatics/symptomatic individuals (Rön-
mark et al. 2005). The study found no statistically significant difference between the in-
halers (Rönmark et al. 2005). After the first demonstration in the trial the following pro-
portion of subjects were able to use the devices without making any mistake: Turbuhaler, 
51 %, Easyhaler, 45 %; Diskus, 43 %. During the end of the four week trial, during which 
additional training was given, the corresponding figures were 89 % for the Diskus, 84 % 
for the Easyhaler and 81 % for the Turbuhaler. 
 
4.5 Patient preferences and inhaler satisfaction  
 
Patient preference is an important factor to be taken into consideration when determining 
treatment for an asthma patient. It has even been argued that patient preference might be 
the most important factor to consider when prescribing a treatment, as even the most ef-
fective treatment will not lead to disease control if it is not followed, or if it is used inac-
curately (Chrystyn 2005). Some factors regarding treatment preference and adherence of 
asthma patients can be linked to the intrinsic nature of asthmatic symptoms (Price et al. 
2013). One of these factors is considered to be easy access, use and fast relief from an 
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inhaler in the event of an asthmatic attack. An uncomplicated treatment regimen, prefer-
ably with once daily medication, would seem to be desirable for a majority of asthma 
patients (Price et al. 2011).  
 
Researchers have proposed that patients who use their preferred inhaler might obtain a 
greater degree of satisfaction with therapy (Anderson 2005). This could be an important 
advantage for both patients and caregiver in regards to the patient’s therapy. Furthermore, 
it has been suggested that higher satisfaction with inhalers may lead to a higher degree of 
adherence, improved clinical outcomes and thereby reduced healthcare expenditures (An-
derson 2005). Data supporting these types of associations are, however, scarce even 
though some supporting data has been found. Research by Small et al. (2011) indicates 
that in real-world situations, the majority of patients’ who expressed a high level of sat-
isfaction for their inhaler device were more likely to be observed as compliant to their 
therapy and to experience better outcomes. As such the level of a patient’s satisfaction 
with their inhaler device was observed to have a positive impact on the treatment goals 
for asthma. 
 
When assessing the patient’s preference for an inhaler device it is important to take a 
number of factors into consideration, these include the clinical benefit of the medicine 
and adverse effects (drug dependent), economics and sociocultural factors, such as be-
liefs, knowledge and education, ease of use, dosing schedule, portability and taste, (Small 
et al. 2011). Lenney et al. (2000) suggest that the delivery of a drug can be maximized by 
appropriately prescribing, and assessing which devices patients can use efficiently. Pa-
tient preference may also be useful for assessing the patient’s acceptance, and hence com-
pliance, with the device.  
 
There are some patient preference comparisons available for the inhalers used for this 
study. All of the previous research has, however, focused on comparing only two or three 
of the inhalers and to date no research comparing all four inhalers has been found. The 
fact that many preference studies are being sponsored by pharmaceutical companies 
needs to be considered when reviewing the results of these studies. Anderson (2005) 
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found that out of 23 reviewed studies sponsored by the pharmaceutical industry, the spon-
sor’s device was preferred in 19 cases. Since this may influence the results, sponsorships 
and affiliations with pharmaceutical companies has been stated in the preference reviews 
below.  
 
Due to the fact that Ellipta is a newcomer to the market there were not many preference 
studies available. One study was, however, found. The study measured patient satisfac-
tion and preference among asthma and COPD patients through qualitative interviews. 
Results showed that 71 % of participants with asthma, and 86 % of participants with 
COPD, preferred the Ellipta to the Diskus. Additionally the study indicated a clear pref-
erence for Ellipta over metered dose inhalers and HandiHaler. The study was sponsored 
by GSK (Svedsater et al. 2013). 
 
Several studies comparing preference for Diskus and Turbuhaler were found. Out of three 
studies examined one indicated preference for Turbuhaler over Diskus, and two indicated 
preference of Diskus over Turbuhaler (van der Palen et al. 1998; Schlaeppi et al. 1996; 
Serra-Batles et al. 2002). The first study was a sequential comparison where 50 % partic-
ipants expressed preference the Turbuhaler (34 % preferred Diskus and 16 % were unde-
cided) (van der Palen et al. 1998). The results in this study were not significant. In the 
two other studies preference was determined through and inhaler demonstration an inter-
view (Schlaeppi et al. 1996; Serra-Batles et al. 2002). Both studies indicated preference 
for Diskus over Turbuhaler (65 % and 60 % preference over Turbuhaler). In all three 
studies Turbuhaler was preferred over the Diskus regarding factors related to size and the 
dose counter of the Diskus was preferred over the Turbuhaler (van der Palen et al. 1998; 
Schlaeppi et al. 1996; Serra-Batles et al. 2002). Findings by van der Palen et al. (1998) 
showed a preference for Turbuhaler in the number of available dosages. All three studies 
were sponsored by GSK (Anderson 2005). No studies comparing Turbuhaler and Diskus, 
sponsored by Astra Zeneca were found. This is most likely due to the fact that Turbuhaler 
was launched about 7 years earlier than Diskus and that the GSK sponsored studies were 
conducted in the context of Diskus launching. 
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Research comparing the Easyhaler to either Turbuhaler or Diskus and Turbuhaler was 
found. The studies found indicated a preference for Easyhaler in comparison to Diskus or 
Turbuhaler. When the Easyhaler was compared with Turbuhaler in a group of 79 DPI-
naïve asthmatic patients, the results indicated higher preference for Easyhaler (Jeger et 
al. 2000). In this study 59 % of participants preferred the Easyhaler, 33 % preferred the 
Turbuhaler, and 7 % of participants rated them the same (Jager et al. 2000). Preference 
for Easyhaler over Turbuhaler is supported by another study comparing ease of use for 
the Turbuhaler and the Easyhaler in a group of 32 asthma patients (Zetterström et al. 
2000). Results indicate that a majority of patients who reported the Turbuhaler as their 
own inhaler considered the Easyhaler better, or much better, than the Turbuhaler (Zetter-
ström et al. 2000). All of these comparative studies where sponsored by or affiliated with 
Orion Pharma. 
 
Finally one study comparing three of the four inhalers used in this study was found. This 
was a patient preference study judging patient satisfaction for the Turbuhaler, Diskus/Ac-
cuhaler and the Easyhaler. The study found Easyhaler to be the most satisfactory for pa-
tients. Unlike the other articles examined this study indicated no sponsorship or affilia-
tions with any pharmaceutical company. Out of 30 patients 53 % indicated Easyhaler was 
their first choice. The corresponding figures were 27 % for Turbuhaler and 20 % for 
Diskus. The participants of this study habitually used inhaled corticosteroids, and 83 % 
of participants had prior experience with one of the devices used in the study (Giner et al.  
2004). 
 
4.6 Inhaler education and instructions 
 
Patient education plays one of the most important roles in the patients’ use and misuse of 
asthma inhalers (Fink & Rubin 2005). It has been suggested, that inhalers represent tech-
nology that is considered to be so intuitive and easy to use, that a large part of patients 
and prescribers do not receive sufficient training in their use (Fink & Rubin 2005). The 
cost implications of incorrect inhaler use are many, and manifest themselves in areas, 
such as doctor visits, hospitalizations and medication. Research suggests that these costs 
can be reduced by spending more time on the education of inhaler use (Lenney et al. 2000; 
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King et al. 1991). Many patients are not aware of the fact that they use their inhalers 
inadequately, and they often overestimate their own abilities (Erickson et al. 1998; 
Hämmerlein et al. 2011). 
 
Asthma education can provide added value to asthma patients as it empowers them to 
manage their disease and increase awareness to danger signs (Sanchis et al. 2013). Pa-
tients with a positive attitude towards their therapy have been found more likely to adhere 
to the medical regimen prescribed to them. In a methodical review of educational pro-
grams for asthma, education in self-management was associated with better lung function, 
reduced school absenteeism and less visits to the emergency departments (Guevara et al. 
2003). This was a systematic review study focusing on the effects of educational inter-
ventions in children and adolescents.  
 
The knowledge of proper inhaler use is often incomplete, not only amongst patients, but 
also amongst health care professionals (Price et al. 2012: Self et al. 2007). Self et al. 
(2007), among others, showed that a majority of health care professionals displayed lack 
of skill, while demonstrating the use of various asthma inhalers. This information ulti-
mately gives rise to the question: If health care professionals are unaware of how to use 
certain inhalers, how are they supposed to teach patients how to use them. Research has 
shown that between 28-68 % of patients do not use metered-dose inhalers or powder in-
halers well enough to benefit from the prescribed medication (Fink & Rubin 2005). In 
addition, between 39-67 % of nurses, respiratory therapists and doctors are unable to suf-
ficiently describe, or perform, critical steps for inhaler use. This observation is supported 
by Price et al. (2013) who suggest that only 15-69 % of health care professionals were 
able demonstrate correct inhaler use. This can be seen as an alarming statistic as health 
care professionals play an important role in patients attaining their goal of achieving cor-
rect inhaler technique and maintaining it over time. 
 
Many studies regarding the efficiency of different training methods have been made to 
evaluate, which one is optimal for achieving correct inhaler technique. There are several 
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different approaches available for training in inhaler technique. These include written in-
structions, illustrations, audio visual demonstrations, interactive computer programs as 
well as personal and small group demonstrations (Lavorini 2013: Sanchis et al. 2013). 
 
Roberts et al. (1982) suggest that provision of the manufacturer’s instruction sheet alone 
was ineffective as a method of providing inhaler instructions, partially due to the fact that 
patients tended to overlook this information. Other studies have shown that this form of 
training is inefficient, even for those patients who actually read the leaflet (Melani et al. 
2004). For instance, a study measuring the technique for Turbuhaler found that only 6 % 
demonstrated a correct technique with Turbuhaler after receiving the instructions, and 
after 3 days of use, 36 % were still not able to use it correctly (Nimmo et al. 1993 as seen 
in Rönmark et al. 2005). The participants of the before-mentioned study were only given 
the instructions included in the package insert and were not provided any other assistance. 
Personal instructions provided by a pharmacist have been found more effective than writ-
ten instruction and inclusion of a physical demonstration were found to improve the in-
structed patient’s inhaler technique (Basheti et al. 2005).  
 
Personal and small group demonstrations of interactive nature have, so far, proven to be 
the most effective alternatives (van der Palen et al. 1997). These educational methods 
have proven to be far more effective than, for example, video demonstrations (Lavorini 
2013). Periodic retraining is needed as inhaler technique declines over time, it has been 
found that the technique must be repeated regularly in order to achieve and maintain cor-
rect technique (Takemura et al. 2010; O'Bey et al. 1982). Health care professionals play 
an important role in the achieving correct inhaler technique and maintaining it over time. 
Wilson et al. (2010) found that the use of video and print interventions also can promote 
recall on inhaler use in asthma patients. Research suggests patient knowledge and under-
standing can be improved by combining visual images and words using video technology 
(Ferguson 2012). A lack of videos that are sensitive to health literacy 1 makes routine 
cost-effective implementation difficult. 
                                                 
1 WHO defines health literacy as ”the cognitive and social skills which determine the motivation and ability 
of individuals to gain access to, understand and use information in ways which promote and maintain good 
health”  
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Mechanical or computer-based devices have been found to aid in technique training and 
these methods could prove to be both useful and time-saving additions to one-on one 
training sessions with a doctor, nurse or pharmacist (Hardwell et al. 2008). Their value 
must, however, not be overestimated, as a substantial proportion of patients still have 
incorrect inhalation technique despite several training sessions. Research of instructional 
videos in e-learning has found that students who were provided interactive educational 
videos achieved significantly better learning performance and a higher level of learner 
satisfaction than those who were provided a non-interactive video or no video at all. The 
findings of the study strongly indicated that it may be important to integrate interactive 
instructional video into e-learning systems (Zhang et al. 2006). 
 
4.7 Factors that should influence the selection of an inhaler device 
 
There are several international and national guidelines which have been created to guide 
patients in the process of their asthma treatment. Despite of this, Dolovich et al. (2005) 
argue that there are not enough guidelines based on scientific evidence. There are a num-
ber of factors that play a part in choosing the best inhaler for a patient.  Currently there is 
no inhaler available on the market that would meet every patient’s needs, and therefore 
the choice of an asthma inhaler has to be tailored to each patient individually taking their 
characteristics and needs into careful consideration (Hess 2008; Roche et al. 2013). 
 
When choosing the most suitable treatment for a patient there are several factors that need 
to be taken into consideration. Roche et al. (2013) suggest that based on the patients age 
and clinical conditions, physicians should aim to choose an inhaler that the patients is 
able to use correctly. When prescribing inhalers to special populations, such as children 
or elderly, many distinctive elements need to be considered (Dolovich et al. 2005). These 
populations often display difficulty with coordination and the triggering of the device. 
Elderly patients frequently exhibit deteriorated agility in their hands, therefore it may 
become difficult to operate certain inhaler devices (Hess 2008). Inhalation flow rate is 
another factor that needs to be taken into consideration when prescribing asthma inhalers 
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for special populations, such as the elderly and children. This is important as a high 
enough inhalation flow rate is required in order for the therapy to be efficient.  
 
Some cases of asthma require the patient to use several inhalers. If this is the case it is in 
the interest of the patient to prescribe as similar inhaler devices as possible (Khassawneh 
et al. 2008). Patients who use several different inhalers are at a higher risk of getting 
confused with the instructions, and they usually require more time to learn how to use 
their devices correctly (Melani 2007). If possible, doctors should try to prescribe combi-
nation preparations, rather than separate inhalers for each active ingredient. Combination 
inhalers decrease the number of doses needed throughout the day (Rau 2005). A lower 
number of daily doses have been shown to increase the patient’s adherence to the pre-
scribed therapy (Rau 2005; Melani 2007). 
 
Research by Melani et al. (2007) suggests that the preferences of the prescribing doctor 
and the patient play a central part in the patient’s adherence to the prescribed therapy. The 
time it takes for the patient to administer a dose, the ease at which the inhaler device is 
cleaned and its portability, and durability are also factors that need to be considered when 
prescribing an inhaler device (Melani 2007; Hess 2008; Chrystyn & Price 2009). The next 
chapter will examine different inhaler types and their distinguishing properties.  
 
4.8 The characteristics of an ideal inhaler  
 
When aspiring to design an ideal inhaler the needs of the patient should be placed in 
center of the development process. High levels of device reliability, patient acceptance 
and clinical efficacy are essential in this process (Ashurst et al. 2000). Many characteris-
tics of the inhaler affect these factors. One major challenge in the development of an ideal 
inhaler is that needs vary between patients. Schichilone (2015) states that in reality there 
is no such thing as an ideal inhaler and that one size fits all approaches are not the solution 
to the problem. Instead an adapted selection of the device based on patient preferences 
and perceptions should be encouraged and implemented in clinical practice. It is im-
portant that the patient is able to achieve and maintain proper inhalation technique as this 
ultimately effects the efficacy of treatment. 
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The fact that inhaler needs vary greatly between different patients makes it difficult to 
develop inhalers. Some characteristics have, however, been established as important to 
consider when aspiring to develop and ideal inhaler. The inhaler has to be simple to use, 
easy and convenient to carry around it should contain multiple doses (Ashurst et al. 2000; 
Newman 2004). The inhaler should also have an audiovisual indicator of doses remaining 
as this makes use easier for the patient (Ashurst et al. 2000). In order to increase patient 
acceptance and ease of use the inhaler should also include a feedback mechanism that 
informs the patient of dose administration (Ashurst et al. 2000; Newman 2004). The de-
sign of the inhaler should enable product stability in the device and protect the medicine 
from moisture (Newman 2004). Cost-effectiveness is another important property of an 
ideal inhaler (Clark 1995). When looking at factors that influence clinical efficacy and 
reliability it is important to highlight that the inhaler should display an accurate and uni-
form dose delivery over a wide range of inspiratory flow rates (Ashurst et al. 2000; 
Chrystyn 2006; Newman 2004). Moreover the formulation of an ideal inhaler should dis-
play optimal particle size of the drug as this is crucial for achieving deep lung delivery 
(Clark 1995). Finally it is important that an ideal inhaler shows suitability for a wide range 
of medications and doses (Newman 2004). 
 
Table 2 lists the most important characteristics of an ideal inhaler complied from a num-
ber of articles on the subject. In addition to the above mentioned features, an ideal inhaler 
should contain as few additives, propellant gases and excipients as possible (Melani 
2007). Another aspect of an ideal inhaler is that it should not require an external power 
source or apparatus in order to work, and it should have as little need for maintenance as 
possible. A final identifying aspect of an ideal inhaler would be that it would have little 
or no harmful effect on the environment. 
  
24 
 
 
 
Table 2: Characteristics of an ideal inhaler. 
Drug delivery 
 Excellent drug delivery  
 Targeted, optimized and reproducible delivery 
 Little or no delivery active ingredient to the mouth and larynx 
 Full dose generation even at lower inspiratory flow rates  
 Fast aerosolization of the dose enabling the possibility of taking a new dose immedi-
ately after 
 Dose precision in all environmental conditions 
Inhaler properties 
 Multiple doses 
 Pocket sized and light weighed 
 Dose counter 
 Affordable and cost effective 
 Little or no harmful effect on the environment 
 Suitable for use in all clinical and environmental conditions 
 Ability to use with any active ingredient with potent clinical efficacy when adminis-
tered as an aerosol 
 No additives, propellant gases or excipients 
 Suitable for use without requiring external power sources or additional apparatus  
 Little risk of contamination of active ingredient  
Ease of use 
 Simple reconstitution process with few steps  
 Easy to teach and learn 
 Provides feedback on dose administration  
 Little of no need for maintenance  
Source: Modified from Melani (2007), Ashurst et al. (2000) and Newman & Busse (2002). 
 
4.9 Inhaler devices 
 
Inhalation therapies were initially introduced in the 1950’s, when the first a pressurized 
metered dose inhaler (pMDI) was launched (Islama & Gladki 2008). The first DPI was 
introduced in 1967 as a single dose device (Islama & Gladki 2008; Crompton 2004). To-
day DPIs and pMDIs are the most commonly used inhaler devices in the treatment of 
asthma (Lavorini et al. 2008). Asthma treatment through inhaled therapies facilitate high 
lung disposition of the drug with minimized systemic bioavailability. This significantly 
reduces the chance of possible systemic drug interactions (Lavorini et al. 2008). 
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The technical features of inhaler devices have improved steadily since their introduction 
to the market (Lavorini et al. 2008). The inhalers used in this study can be seen as repre-
senting a part of this development as there has been approximately 25 years between the 
launching of the first inhaler in this study (Turbuhaler) and the last (Ellipta). 
 
The effectiveness of the delivered dose highly depends on the correct use of the inhaler 
device. In clinical settings there appears to be no difference between the efficacy a drug 
delivered though pMDIs or DPIs. Studies from patient use in real life have indicated that 
pMDIs are more difficult for the patients to use and, hence, are more often used incor-
rectly (Lavorini et al. 2008; Molimard et al. 2003; Crompton 2004). This ultimately af-
fects the efficiency of the therapy. DPI’s were originally developed in an effort to make 
the inhalation easier for the patient. One of the major benefits of DPIs in comparison to 
pMDIs is that they enable the patient to inhale the drug without the coordination and 
actuation required when using pMDIs (Lavorini et al. 2008). Table 3 below shows the 
advantages and disadvantages of DPIs in comparison to pMDIs.  
 
Table 3: The advantages and disadvantages of dry powder inhalers in comparison to pressurized 
metered dose inhalers.  
Advantages of DPI’s Disadvantages of DPI’s 
 Free from propellants 
 Less need for patient coordination 
 Less potential for extractable from device 
components 
 Less potential for formulation problems 
 
 More expensive than pMDIs 
 Design issues, such as device resistance 
 Dependency inspiratory flow rate and 
profile of the patient 
 Potential for problems in dose uniformity 
Source: Arshurst et al. (2000) 
 
This study will focus on DPIs and include four inhalers sold on the Finnish market. The 
next chapter will present the specific characteristics of DPIs and the types of DPIs used 
in this study. 
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4.10 Dry powder inhalers 
  
Dry powder inhalers (DPIs) are devices that deliver dry powder formulations of an active 
ingredient for either local or systemic effect through the pulmonary route (Islama & 
Gladki 2008). Dry powder formulations are often a mixture of the active pharmaceutical 
ingredient and an excipient. DPIs use the inspiratory flow energy to deliver the drug dose 
to the respiratory tract (Crompton 2004). Table 4 lists all of the DPIs that are currently 
available on the Finnish market.  
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Table 4: Dry powder inhalers sold on the Finnish market (Pharmaca Fennica 2015; Fimea 2015). 
*    Each medicinal product may have several strengths. 
** API - Active pharmaceutical ingredient. 
 
In order to work correctly, all DPIs require an inspiratory flow rate of between 30 l/min 
and 90 l/min (Al-Showair et al. 2007; Dolovich & Dhand 2011). DPI’s with medium re-
sistance to airflow are designed to operate at an optimum inspiratory flow rate of 60 
l/min. This rate may, however, not be reached by all patients. Reaching a high enough 
inspiratory flow rate may prove especially challenging for populations, such as children 
under the age of six, elderly or patients with gravely impaired lung function (Janssen et 
Name * Device Manufacturer 
Number  
of doses 
API** 
Spiriva Handihaler 
Boehringer Ingel-
heim 
30, 60 and 
90 capsules 
Tiotropium 
Bricanyl Turbuhaler Astra Zeneca 200  Terbutaline 
Oxis Turbuhaler Astra Zeneca 60  Formoterol  
Pulmicort Turbuhaler 
 
AstraZeneca 
100, 200 Budesonid 
Symbicort, 
(also Forte and 
Mite) 
Turbuhaler Astra Zeneca 
60 (Forte), 
120 
Budesonide, formoterol 
Flixotide Diskus GSK 60 Fluticasone  
Seretide Diskus GSK 60 Salmeterol, flutikason 
Ventoline Diskus GSK 60 Salbutamoli 
Relvar Ellipta GSK 30 
Fluticasone,  
Vilanterol 
Novopulmon Novolizer Meda 100, 200 Budesonide 
Ventilastin Novolizer Meda 200 Salbutamol 
Bufomix Easyhaler Orion 60, 120 Budesonide, Formoterol 
Beclomet Easyhaler Orion 100, 200 Beclometasone 
Budesonid Easyhaler Orion 100, 200 Budesonide 
Buventol Easyhaler Orion 200 Salbutamol 
Fomeda Easyhaler Orion 120 Formoterol 
Formoterol Easyhaler Orion 120 Formoterol 
Foradil Aerolizer Novartis 30, 60 Formoterol 
Asmanex 
Twisthaler 
Twisthaler Schering-Plough 30, 60 Mometasone 
Cycloterol 
Cycloterol-
inhaler 
Laboratoires 
SMB 
60 Formoterol 
Formaxa 
Formaxa-in-
haler 
Laboratories 
SMB 
60 Formoterol 
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al. 2008; Fink & Rubin 2005).  
 
Each DPI requires a priming procedure, which is specific to the device in question 
(Sanchis et al. 2013). Understanding and executing the required steps correctly is criti-
cal in order to make the drug obtainable for inhalation. The device specific priming 
steps for the inhalers used in this study will be handled in detail in the methods chapter. 
 
There are several different types of DPIs available on the market. These designs include 
passive, patient driven devices and active, power-assisted devices (Dolovich & Dhand 
2011). Power-assisted devices generally reduce the need for patients to create a high in-
halation rate as the power source assists in ensuring delivery on inhalation. Today DPI’s 
represent the most rapidly expanding field in inhaled therapies (Crompton 2004; Islama 
& Gladki 2008).  The phasing out of chloroflurocarbon (CFC) production was thought to 
have led to increased development of DPIs (Son & McConville 2008; Hendeles et al. 
2007). Another factor that is thought to have increased development is the improved 
availability of drug powders (Dolovich & Dhand 2011).  
 
4.11 Different types of DPI devices and design 
 
There are three main categories of dry powder inhalers; pre-metered single dose inhalers, 
pre-metered multi-dose inhalers and multi-dose reservoirs (Wright 2009). The inhalers 
included in this study belong to the two latter categories. As such, these two categories 
will be explained in further detail below. 
 
4.11.1 Multi-dose DPIs 
 
Multi-dose DPI devices are defined as DPIs that contain more than one dose (Chrystyn 
2007). These inhalers can further be divided into two categories: multi-dose reservoir 
devices and multi-unit devices. 
 
Multi-dose reservoir devices release individual doses with each actuation from a bulk 
supply of the pharmaceutical held within the inhaler device (Chrystyn 2007). The first 
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multi-dose reservoir device that was introduced to the market was the AstraZeneca’s Tur-
buhaler, which is used to deliver corticosteroids as well as β2-agonists, either separately, 
or in combination (Wetterlin 1988). Other multi-dose reservoir inhalers currently for sale 
on the Finnish market include the Easyhaler (Orion) and the Twisthaler (Schering 
Plough). These are all newer than the Turbuhaler and throughout their design have been 
said to focus on minimizing the flow dependent dose emission that has been said to occur 
in the Turbuhaler (Chrystyn 2007). Another aspect designers have focused on, is adding 
features that would protect the formulation in the inhaler from moisture during patient 
use and storage. The Easyhaler has a protective case to protect the inhaler formulation 
during storage and the hopper on the Easyhaler is designed in order to make it difficult to 
blow into the inhaler. 
 
Multi-unit dose inhalers are set apart from single unit and reservoir inhalers by the prop-
erty that they use individually scaled and prepared, sealed doses of drugs (Chrystyn 2007). 
The first multi-unit dose device introduced to the market was the Aerohaler which con-
tained six unit dose capsules as a magazine. Excipients, such as, lactose are used in multi-
unit dose inhalers to improve the dose uniformity. This is achieved by increasing the mass 
of powder for each dose resulting in minimized inhalation dependent dose emission and 
improvement of the accuracy of dose metering. Due to the fact that the formulations for 
these inhalers are sealed into a blister the design offers both a high level of protection 
against environmental factors like humidity.  Because the doses of the pharmaceutical are 
prepared and separately packaged in the factory, dose uniformity can be secured. 
 
4.12 Dry powder inhalers; the devices used in this study 
 
The four inhalers in this have been chosen as they represent the three most frequently 
prescribed dry powder inhalers for asthma in Finland; the Diskus, Turbuhaler and 
Easyhaler, as well as the most recent newcomer to the Finnish market, Ellipta.  The in-
halers used in this study can be seen as representing a development of DPIs over a 25 
year period as there has been approximately 25 years between the launching of the oldest 
and newest inhaler used in this study. Figure 2 describes the timeline for launching each 
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of the inhalers used in this study. In this chapter the characteristics for each inhaler will 
be presented in further detail. 
 
 
Figure 2: Timeline for when the inhalers used in this study was launched. 
 
4.12.1 Turbuhaler 
 
Turbuhaler was first introduced in 1988 and is today the second most sold dry powder 
inhaler on the Finnish market (GSK Sales data 2013). The Turbuhaler was the first multi-
dose reservoir DPI that was introduced to the market and the inhaler dispenses metered 
doses from a reservoir inside the inhaler (Wetterlin 1988; Newman & Busse 2002). The 
drug formulation is used in the Turbuhaler inhalers is agglomerated. When first intro-
duced the Turbuhaler was used to deliver corticosteroids as well as β2-agonists, either 
separately, or in combination in the treatment of asthma (Wetterlin 1988). During its time 
on the market the inhaler has been used to deliver formulations of terbutalinesulphate, 
formoterol, salbutamolorbudesonide or a combination of budesonide and formoterol 
(Symbicort) (Newman & Busse 2002).  
 
The active ingredient is located within the inhaler in the Turbuhaler it is formulated as a 
pellet of soft aggregates of drug in its micronized form (Chrystyn 2007).  The pellets are 
approximately 0.5 mm in diameter without any excipient (Newman & Busse 2002). These 
pellets can either contain lactose monohydrate as an excipient or the active ingredient can 
stand alone (Chrystyn 2007). Of the medicines using Turbuhaler as a device on the Finn-
ish market, Oxis and Symbicort Turbuhaler both contain lactose monohydrate as an ex-
cipient in the pellets, whereas Bricanyl Turbuhaler and Pulmicort Turbuhaler contain no 
excipients (Pharmaca Fennica 2015). Figure 3 shows the structure of the Turbuhaler and 
identifies the different components of the inhaler. The blue arrows represent the air flow 
that is created within the device upon inhalation. 
1988
Turbuhaler
1992
Easyhaler
1995
Diskus
2013 
Ellipta
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Figure 3: The design scheme of the Turbuhaler. The blue arrows represent the air flow that is 
created upon inhalation, according to Azouz & Chrystyn (2012). 
 
In order for patients to release a dose from the Turbuhaler patients twists the base of the 
inhaler, while holding it in a vertical position (Chrystyn 2007). This leads to a dose being 
shaved off of the pellet. Due to this dosing mechanism it is essential that the Turbuhaler 
be kept in an upright position. It is essential that the upright position is held for all reser-
voir DPIs as they depend on gravity to fill the dose metering cup (Chrystyn 2007). The 
aerosol dispersion mechanism of the Turbuhaler is based so called discharge channels 
(Frijlink & De Boer 2004). The aerosol is conducted through specifically shaped dis-
charge channel, or channels with helical inserts. 
 
As the patient inhales through the device the dose is dispersed by turbulent airflow 
(Chrystyn 2007). The energy, which is created by the turbulent air flow then disperse the 
particles in the emitted dose. These particles are sufficiently small to have a high proba-
bility of depositing in the conducting airways (Chrystyn 2007).   
 
  
32 
 
 
4.12.2 Easyhaler  
 
Easyhaler is a multi-unit reservoir dry powder inhaler that can hold up to 200 doses of 
drug formulation (Newman & Busse 2002). The Easyhaler is marketed by Orion Pharma 
and has been used to deliver formulations of salbutamol and BDP with lactose monohy-
drate acting as an excipient. The first Easyhaler was launched into the Finnish market in 
1992 (Orion 2015). 
 
Even though the Easyhaler is a DPI reservoir device, the shape and operating sequence 
of the inhaler is rather similar to those of pMDIs (Smith & Parry-Billings 2003). The 
Easyhaler consists of seven plastic components and one spring made of stainless steel. 
The reservoir in the device contains the powdered drug formulation. Below the reservoir 
there is a metering cylinder with dose cavities that on its surface. The metering cylinder 
is able to rotate and thereby dose the powder in the reservoir. The Easyhaler utilizes the 
Venturi effect2 as its aerosol-dispersion mechanism, and the aerosol passes through nar-
row tubes, or so called venturi tubes, upon delivery (Frijlink & De Boer 2004). 
 
Picture 1 in Figure 4 shows a cross-sectional cut of the Easyhaler. Picture 2 in Figure 4 
depicts how the device functions when the patients performs an inhalation correctly. First 
the dosing cup is filled up when the patient shakes the device, while simultaneously hold-
ing it in an upright position. Thereafter the device actuation rotates the dosing cup into 
the inhalation channel whereby the dose is ready for inhalation. The inhalation performed 
by the patient creates a turbulent airflow in the dosage channel. This turbulent airflow 
causes the drug-carrier complex to break up into its constituents. The inhalation delivers 
the active ingredients to the lungs where it acts systemically (Chrystyn 2006). 
                                                 
2 Merriam Webster’s dictionary defines the venturi effect as “a short tube with a tapering constriction in 
the middle that causes an increase in the velocity of flow of a fluid and a corresponding decrease in fluid 
pressure and that is used especially in measuring fluid flow or for creating a suction (as for driving aircraft 
instruments or drawing fuel into the flow stream of a carburetor)” 
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Figure 4: Cross-sectional picture of the Easyhaler inhaler accompanied by a schematic design 
explaining how the dose is generated during inhalation, Chrystyn (2006). 
 
4.12.3 Diskus 
 
Diskus (GSK) is a multi-dose dose device that was first introduced to the market in 1995 
and is currently the most frequently sold inhaler on the Finnish market (GSK Sales data 
2014). The Diskus is a multi-unit dose device and can be considered a further develop-
ment of its predecessor the Diskhaler. The Diskus was designed to simplify the use of the 
Diskhaler by removing the need to manually load the inhaler with cartridges and provid-
ing a larger number of doses. 
 
The Diskus contains a coiled strip of 60 individual, pre-metered, double foil-wrapped 
blister doses that provide up to 1 month’s medication (Chrystyn 2007). The double alu-
minum blister foil assures that each individual dose is protected from environmental fac-
tors, such as moisture, dust and light. Each blister contains small drug particles mixed 
with larger lactose particles that act as a carrier (Borgström et al. 2005). The inhaler has 
been used to deliver active ingredients, such as fluticasone propionate, salbutamol, sal-
meterol xinafoate and a combination preparation of fluticasone propionate and salmeterol 
xinafoate (Newman & Busse 2002). There are several medicines using the Diskus as a 
delivery device currently available on the Finnish market. 
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The Diskus is constituted and activated by sliding a lever which transfers the next blister, 
containing a new dose, into place. The device also contains a ratchet, which causes the 
inhaler to click when the next dose is positioned properly (Chrystyn 2007). When the 
device is primed in this way, it leads to the two foil layers being simultaneously peeled 
apart, thereby exposing the dose and getting the device ready for inhalation. The Diskus 
also contains a dose counter through which the patient can monitor the amount of doses 
remaining in the device. Furthermore, the device has an integral outer case which serves 
the purpose of keeping the inhaler dust free, in addition to resetting the lever. Table 6 lists 
critical errors that can be made when using the Diskus inhaler. 
 
The Diskus is a so called passive inhaler (Chrystyn 2007). In practice this means that the 
patient’s inhalation disperses the formulation and the therapeutic dose, which reaches the 
lungs may vary with the strength of the inhalation. Figure 5a shows the different parts of 
the Diskus and the blue arrows depicts the airflow that occurs during inhalation. Figure 
5b shows a cross-sectional schematic design of the inhaler. 
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Figure 5a and 5b: Figure a) shows the structure and design of the Diskus inhaler. The blue arrows 
depict the airflow that occurs during inhalation. Figure b) shows a cross-sectional schematic de-
sign of the inhaler (Chrystyn 2007). 
 
The fine particle fraction of the active ingredients used in a dose delivered by Diskus is 
considered to be low, approximately 20 %. Fine particle fraction is defined as the fine 
particle dose divided by the dose that is actually delivered (Derom & Thorsson 2001). 
The fine particle dose is defined as the dose which is delivered in particles that are smaller 
than 5 μm in diameter  
 
4.12.4 Ellipta 
 
The Ellipta is a handheld multi-unit dry powder inhaler that is relatively new on the Finn-
ish market. Relvar, which is the only medicinal product using the Ellipta inhaler on the 
Finish market has a formulation that contains flutikasonfuroate and vilanterol as active 
ingredients and lactose monohydrate and magnesium stearate as excipients. Like in most 
DPI formulations lactose monohydrate acts as a carrier. Magnesium stearate is increas-
ingly being used as an excipient in dry powder formulations in an attempt to reduce the 
inter-particulate bonds between carrier and drug particles (Begat et al. 2009; Traini et al. 
2012; Hoppentoch et al. 2014). This is accomplished with the use of dispersion agents, or 
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so-called force control agents (FCAs), such as magnesium stearate (Begat et al. 2009; 
Traini et al. 2012; Zhou et al. 2013). 
 
Scichilone et al. (2014) suggests that Ellipta belongs to a category of novel inhaler devices 
designed to be more intuitive than its older counterparts. These inhalers have been de-
signed to operate according to a simple open–inhale–close operation that ensuring ease 
of use for the patient. The main scope of these new devices is to meet the needs of the 
patient, by simplifying the inhalation maneuvers and thereby improving adherence to 
treatment due to fewer mistakes during loading (Scichilone et al. 2014). Ellipta is acti-
vated with a single step action featuring a cover that is opened by the patient to uncover 
the mouthpiece, thereby activating the dose in the inhaler (Svedsater et al. 2014). 
 
A recent exploratory study, suggests that many of Ellipta’s attributes are viewed as posi-
tive by asthma and COPD patients (Svedsater et al. 2013). The attributes found to be 
positively viewed by patients included simplicity of operation, ease of use, the visibility 
and ease of interpretation of the dose counter, the design ergonomics as well as the feel 
and fit of the inhalation mouthpiece. Figure 6 shows the design and structure of Ellipta 
and how it is supposed to be operated by patients.  
 
Figure 6: The three-step process for operating the Ellipta inhaler. Picture a) shows the different 
components of the inhaler, picture b) demonstrates the use of the inhaler and picture c) shows that 
the inhaler when the cover is on the inhaler and the inhaler is not being used (Lavorini et al. 2014).   
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4.13 Research gap 
 
Many studies have addressed improper inhaler technique. Despite of this it remains a 
wide spread problem among asthma patients (Crompton et al. 2006; Lavorini et al. 2008). 
Most of the studies on the matter have measured the technique of asthma or COPD pa-
tients with prior inhaler experience. This study targets healthy inhaler naïve individuals 
and aims to investigate how easily they learn to use the inhalers in this study. The study 
measures the frequency of inhaler errors after receiving a video demonstration of the cor-
rect inhaler technique. Comparing how the four inhalers are used and perceived by inhaler 
naïve individuals may help prescribers better understand the needs of asthma patients 
with no prior inhaler experience. 
 
Due to the fact that Ellipta is relatively new on the market, few studies regarding the 
inhaler technique have been conducted. The ones performed have mainly addressed in-
haler technique in a clinical environment. In other cases the target population has been 
much older than that of this study. Hence this study may provide valuable information on 
the perception of Ellipta and the inhaler technique for it in the age group 24-35 years old.  
 
The foundation for this thesis is the idea that easily accessible education in combination 
with a patient friendly and intuitive inhaler device that leave little room for mistakes could 
be a step towards reduced inhaler error frequency and increased adherence among asthma 
patients. Video instructions have been used as an easily accessible teaching method 
through which patients can get correct standardized instructions whenever they need to. 
Even though video instructions are commonly used for providing inhaler education, little 
research regarding the efficiency of this educational method exists. As a result, this study 
aims to evaluate video instructions as a teaching tool and investigate whether this educa-
tional method could be further developed in the future. Addressing the issue of incorrect 
inhaler use among patients is important as decreasing the amount of inhaler errors could 
not only contribute to a higher quality of life, but also reduced costs from a healthcare 
and societal point of view (Sullivan 2005).  
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5. Method 
 
5.1 Data collection and analysis 
 
This study used a triangular method for data collection. Methodological triangulation 
implies a method that combines different methods of data collection (Hämeen-Anttila & 
Katajavuori 2008a). Quantitative data was collected through semi-structured interviews 
using the questionnaire frameworks that can be found in Appendix 1 and 2. All of the 
participants were asked to fill in a total of 5 questionnaires, including one for each device. 
In addition, observational qualitative data was collected through videotaping of the par-
ticipants and note taking during the inhalation process. The data collection plan, including 
questionnaires as well all other material distributed to the participants, was reviewed and 
approved by the Ethical Review Board in the Humanities, Social and Behavioral Sciences 
at the university of Helsinki.  
 
The questionnaires used for this study was built up as a structured interview and contained 
both open ended and closed questions. The participants were able to ask clarifying ques-
tions while filling in the questionnaires. This was considered to possibly eliminate the 
risk of misunderstandings among participants. 
 
First the participant filled in a questionnaire containing closed, multiple choice questions. 
The purpose of this questionnaire was to collect information in the form of control varia-
bles and make sure that all participants fulfill the criteria for participating in the study. 
The purpose of the second questionnaire was to measure the participants’ perception of 
each inhaler’s different properties, their user experience and perception of the educational 
material. An identical questionnaire was completed for each device. The subjects’ re-
sponses to questions assessing their perception of different aspects of the devices were 
elicited using a five-point Likert scale (strongly disagree, disagree, neutral, agree and 
strongly agree). In addition the questionnaire contained some open questions. The pur-
pose of these questions were to give participants the opportunity to elaborate more freely 
on their opinions regarding the devices. 
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Before starting the process of data collection, the process was piloted. One individual 
acted as pilot for this study. After completing all four inhaler demonstrations the partici-
pant remembered he might have been prescribed one of the inhalers for a cough. Further-
more, the piloted individual did not receive the same instructions as the rest of the partic-
ipants of the study. Due to these two factors the results may not have been comparable 
and the pilot was excluded from the results. As a result of the piloting, the procedure of 
additionally asking, if the participants had been prescribed any of the inhalers for any 
other purposes than asthma/COPD was added. In the pilot some issues regarding the in-
structions given to the participants arose. After the pilot testing of the data collection 
process, a checklist for information that were to be given to each participant was con-
structed. This checklist was created in order to assure the repeatability and generalizabil-
ity of the study and it was used for all of the participants throughout the data collection 
process. 
 
The order in which the participants handled the inhalers was randomized by lottery. The 
order in which the inhalers were to be used was determined before the process started. 
Then participants received video instructions for each inhaler. In order to simulate a sit-
uation in which the participants would have been watching the video at home, all partic-
ipants were told that they were allowed to pause and go back in the videos, if they chose 
to do this, they were asked to write it down on their questionnaire paper. 
 
After watching the educational video for a particular inhaler, the participants were asked 
to demonstrate the use of this inhaler. This demonstration was videotaped. Participants 
received no additional verbal or demonstrative instructions during the video demonstra-
tion. They were asked to demonstrate their first attempt of using the inhaler. Subjects then 
crossed over to the other inhalers in a random order. Preference was assessed using a self-
completed questionnaire containing both open and closed questions. All comments made 
by the participants related to the inhalers or the video material were written down and 
used to complement the answers in the open-ended questions. The participants’ inhaler 
demonstrations were filmed and assessed both during the demonstration and afterwards 
from a videotape using an inhaler specific checklist. The participants did not inhale any 
medication in the study, therefore efficacy and safety were not measured. As no PEF 
40 
 
 
meter was used during the study air flow resistance and strength of inhalation were not 
assessed. 
 
The collected data was of both a qualitative and quantitative nature. The quantitative data, 
such as the scores for inhaler handling were put in tables and quantified. After putting the 
quantified collected data in tables it was easy to compare the participants’ answers for the 
different inhalers to one another. 
 
The results from the structured interview were themed into different categories and re-
peated answers and phenomenon’s were observed and noted. The notes made based on 
the participants comments during and after the inhaler testing were also included in these 
themed comments from the structured interviews. The scoring methods for inhaler fre-
quency and preference will be described in further detail in this chapter.  
 
5.2 Video-taping and questionnaires  
 
The participants started the data collection process by filling in a questionnaire with mul-
tiple choice questions. The questionnaire included general information about the partici-
pants’ gender, age, educational level and home town. These questions act as control var-
iables. The first questionnaire also contains questions designed to assure that the partici-
pants are considered inhaler naïve by the definition of this study. The questionnaires and 
educational videos used in this study were provided in Finnish and the outline of the 
questionnaires can be found in Appendix 1 and 2. A small number of the participants 
recruited indicated that their mother tongue was Swedish. In an attempt to eliminate any 
misunderstanding that might have arisen from answering the questions in a language other 
than their mother tongue, Swedish speaking participants were encouraged to answer the 
questions in Swedish. 
 
After filling in the first questionnaire, participants were shown a demonstrational video 
of one of the inhalers produced by the Association of Finnish Pharmacies (Apteek-
kariliitto). After this the participants were asked to demonstrate the use of a particular 
inhaler and this demonstration was videotaped. After demonstrating how they would use 
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the inhaler for which they had just received video instructions, they were asked to fill in 
a questionnaires containing questions regarding the inhaler experience, their perception 
of the inhaler and its properties, as well as, their perception of the educational video. This 
process was be repeated for each inhaler until the patient had seen, and demonstrated the 
use of all four inhalers. The fact that demonstrations were provided via video was a con-
scious attempt to guarantee that the presented instructions were the same each time and 
subsequently avoid that the inhaler demonstration itself would give cause to possible bi-
ases towards any particular inhaler. In order to further avoid biases towards one particular 
inhaler any visible company logos on the placebo-inhalers used were covered with tape. 
 
Previous studies have concluded that it is difficult to observe, measure, and judge inhala-
tion technique, primarily due to the speed in which direct observed inhalation takes place. 
Most studies examining inhalation technique are subjective by design as instructors often 
assess the technique themselves (Rootmensen et al. 2010). Furthermore, investigators are 
often not blinded and little or no information is given about the kind of training received. 
This form of study design raises the prospect of observer bias and the likelihood of poor 
intra-observer repeatability (Rootmensen et al. 2010). Therefore, the videotaped demon-
strations were judged using a predefined checklist specific for each inhaler. When all 
demonstrations had been judged, random checks were carried out in order to ensure that 
no mistakes were made in the judging. The judging of the inhalation videos and the ran-
dom checks were conducted by the same individual several days apart in an attempt to 
create distance between the scoring of one videos.  
 
After completing the video tape demonstration the participants were asked to fill in a form 
with questions regarding their opinions of the inhaler, the instructions given as well as a 
self-evaluation of their own performance. 
 
5.3 Population and sample 
 
People without asthma and no experience of handling asthma inhalers were recruited from 
the general public. The chosen population consisted of 25- 34 year old males and females 
as statistics provided by the National Institute for Health and Welfare (THL) showed that 
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asthma is most prevalent for this age group in the adult population in Finland; this can be 
observed in Table 5 (Borodulin et al. 2013). The distribution of asthma in different age 
groups varies between the sexes. In Helsinki and Vantaa, the age group in which asthma 
seems to occur most appears to be 25-34 years old for both sexes, this can be seen in 
Table 6 (Borodulin et al. 2013). A prerequisite for participation was that all subjects had 
to be entirely inexperienced in inhaler use. 
 
Table 5: Prevalence of asthma in different age groups (Borodulin et al. 2013). 
Finland 
(weighed average) 
Age group (years) 25–34 35–44 45–54 55–64 65–74 
Percentage (%) 12.2 9.0 9.5 8.3 11.5 
Number of participants 1036 1187 1294 1383 1475 
Helsinki and Vantaa 
Age group (years) 25–34 35–44 45–54 55–64 65–74 
Percentage (%) 13.5 7.9 10.3 9.9 9.9 
Number of participants 193 215 251 263 292 
 
Table 6: Prevalence of asthma for men and women between different age groups (Borodulin et 
al. 2013). 
Finland  
(weighed average) 
 Men Women 
Age group (years) 
25–
34 
35–
44 
45–
54 
55–
64 
65–
74 
25–
34 
35–
44 
45–
54 
55–
64 
65–
74 
Percentage (%) 11.5 9.7 9.4 8.0 8.1 12.7 8.4 9.6 12.7 15.0 
Number of participants 444 544 605 661 757 592 643 689 722 718 
Helsinki and Vantaa 
 Men Women 
Age group (years) 
25–
34 
35–
44 
45–
54 
55–
64 
65–
74 
25–
34 
35–
44 
45–
54 
55–
64 
65–
74 
Percentage (%) 11.8 11.8 8.7 5.4 9.0 14.8 4.4 12.0 11.9 11.0 
Number of participants 85 102 126 129 156 108 113 125 134 136 
  
The individuals who belonged to the selected population were made aware of the study 
through fliers posted in a number of relevant locations, such as educational institutions, 
libraries, grocery stores and public places. Individuals who did not belong to the chosen 
age group were excluded from the study. The chosen participants were all individuals 
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living or working in the Helsinki Metropolitan area, as research has shown that asthma is 
more prevalent in larger city populations (Wisnivesky et al. 2005). After this the people 
who had been made aware of the study were themselves able to choose whether or not 
they wanted to participate in the research project. This form of sampling technique is 
called self-selection sampling (Saunders et al. 2012). 
 
Purposive sampling was also used in the recruiting of candidates for this study. When 
using purposive sampling all participants have to fulfill certain predetermined criteria in 
order to be eligible to participate in the study (Hämeen-Anttila & Katajavuori 2008b). For 
example, this study only included participants within a predetermined age group who 
were classified as being inhaler naïve. For the purpose of this study subjects were consid-
ered inhaler naïve if they did not have asthma, nor any experience in using any type of 
inhaler devices. Subjects who indicated that they had worked within the pharmaceutical 
industry, at a pharmacy, or had family members who suffered from asthma, were ex-
cluded from the study as it was considered that their prior experience with a certain 
asthma inhaler could lead to a bias towards a particular inhaler in the study. The data was 
collected during the span of 1.5 months. The long period for data collection stemmed 
from a difficulty in finding volunteers. 
 
At the beginning of the study an aim of reaching a sample size of at least 30 participants 
was set. In the end 31 people ended up participating in the study. The Central Limit The-
orem (CLT)3 determines that when the sample size is 30 or more, the sample size is large 
enough according to the Central Limit Theorem. With this sample size the average could 
be considered to be normal even if the sample does not come from a normal distribution. 
Consequently, when sample size is 30 or more, there is no need to check whether the 
sample originates from a Normal Distribution (Hays 1981). 
 
In the end a total of 31 people participated in this study. The average age of the partici-
pants was 28 years, 17 participants were men and 14 were women. A large majority of 
                                                 
3 According to Merriam Webster’s dictionary CLT is a theorem  which states that the distribution of a mean 
of a sample from a population with finite variance is approximated by the normal distribution as the number 
in the sample becomes large 
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participants in this study had an academic education (23/31), 5 participants had attended 
a university for applied sciences and 3 participants had completed secondary education. 
All participants lived or worked in the Helsinki Metropolitan Area. Two people who had 
announced they were willing to participate had to be excluded from the study. The pilot 
was excluded from the study due to the fact that this person did not receive the same 
instructions as the rest of the participants and had been prescribed one of the inhalers for 
a severe cough. Due to this indiscretion there was a fear that the results would not be 
comparable. 
 
5.4 Scoring method 
 
5.4.1 Scoring inhaler errors 
 
The frequency of error for each inhaler was determined by scoring the participants’ per-
formance and errors were recorded against a predefined list of steps for each inhaler. 
Educational videos produced by the Association of Finnish Pharmacies were used to de-
termine the check lists for each inhaler. Only errors that could influence the efficacy of 
treatment were noted. For the purpose of this study critical errors were defined as errors, 
displays of flawed technique or lack of knowledge in regards to the usage of the inhaler 
device that is likely to impair the delivery of adequate medication on all occasions of drug 
administration (Price et al. 2013). Tables 7-10 show the inhaler instructions patients re-
ceived for each inhaler in the educational videos as well as the errors deemed critical for 
each inhaler. 
 
The assessment form for correct use included six items for all inhalers in this study. The 
assessments vary somewhat from each other depending on the instructions given to par-
ticipants. For example ‘‘Holding one’s breath after the inhalation’’ was assessed for 
Diskus, Easyhaler and Ellipta, but not for Turbuhaler, because this instruction was not 
included in the video instructions.  
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Table 7: The instructions column describes the instructions given in the educational video for 
Turbuhaler. The second column describes the inhaler errors measured for Turbuhaler in this study. 
Inhaler Instructions Errors measured 
Turbuha-
ler 
1. Unscrew the cap and take it off. 
Hold the inhaler upright 
2. Twist the grip of your Turbuhaler 
as far as it will go. Then twist it all 
the way back. When twisting you 
will hear a "click" 
3. Breathe out deeply away from the 
device 
4. Put the mouthpiece between your 
teeth, and close your lips around it. 
5. Breathe in forcefully and deeply 
through your mouth 
6. Remove the Turbuhaler from your 
mouth and calmly breathe out 
through the nose. 
7. Replace the cap 
1. Failure to open device 
2. Failure to hold device in right po-
sition 
3. Failure to emptying lungs before 
inhalation 
4. Failure to load device 
5. Failure to breathe out through the 
nose after inhalation 
6. Exhalation into the mouth piece 
Source: Price et al. (2012); Association of Finnish Pharmacies (2015); van der Palen et al. (1995); 
Melani et al. (2004); Khassawneh et al. (2008) 
 
 For Turbuhaler “breathe out through nose after inhalation” was assessed instead of “hold-
ing ones breathe” (see Table 7). The period for which participants were to hold their 
breath varied depending on the instructions given to them (see Tables 8, 9 and 10). 
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Table 8: The instructions column describes the instructions given in the educational video for 
Easyhaler. The second column describes the inhaler errors measured for Easyhaler in this study. 
Inhaler Instructions Errors measured 
Easyhaler 1. Open the protective cover 
2.  Insert the inhaler in a protective 
case. Make sure that the cover is on 
the mouthpiece. 
3.  Remove the mouthpiece cover 
4.  Shake the inhaler vigorously up 
and down 3-5 times. Do not trigger 
the inhaler when shaking it! 
5. Hold the inhaler upright 
6. Trigger the inhaler once until you 
hear a click and let the inhaler re-
turn to its original position. 
7. Keep holding the inhaler in an up-
right position 
8. Breathe out normally 
9.  Place the mouthpiece in your 
mouth between your teeth and close 
your lips tightly around the mouth-
piece 
10. Breathe in through your mouth in 
forcefully and deeply. Take the 
mouthpiece out of your mouth. 
11. Hold your breath for at least 5 sec-
onds and then breathe out through 
your nose. 
12.  Close the protective cover 
1. Failure to open device 
2. Failure to hold device in right po-
sition 
3. Failure to emptying lungs before 
inhalation 
4. Failure to load device 
- Failure to shake device  
- Failure to press button  
- Loading in wrong order 
- Triggering inhaler when shaking 
it 
5. Failure to hold breath at least 5 
seconds after inhalation 
6. Exhalation into the mouth piece 
Source: Price et al. (2012); Association of Finnish Pharmacies (2015); van der Palen et al. (1995); 
Melani et al. (2004); Khassawneh et al. (2008) 
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Table 9: The instructions column describes the instructions given in the educational video for 
Diskus. The second column describes the inhaler errors measured for Diskus in this study.  
Inhaler Instructions Errors measured 
Diskus 1. Open your Diskus: Hold it in the 
palm of your hand, put the thumb 
of your other hand on the thumb 
grip and push the thumb grip until 
it "clicks" into place 
2. Load the Diskus by holding the de-
vice with the mouthpiece towards 
you.  Slide the lever away from you 
as far as it will go to get your medi-
cation ready 
3. Adjust your posture. Keep your 
shoulders down and head held high. 
4. Breathe out away from the device 
for as long as you feel comfortable.  
5. Place the mouthpiece gently in your 
mouth and close your lips around it 
6. Breathe in deeply and evenly 
though the Diskus. 
7. Remove the device from your 
mouth 
8. Hold your breath for 5-10 seconds 
9. Calmly breath out through your 
nose 
10. Close the Diskus by sliding the 
thumb grip towards you until you 
hear a click 
1. Failure to open device 
2. Failure to hold device in right po-
sition 
3. Failure to emptying lungs before 
inhalation 
4. Failure to load device 
5. Failure to hold breath at least 5-10 
seconds after inhalation 
6. Exhalation into the mouth piece 
Source: Price et al. (2012); Association of Finnish Pharmacies (2015); van der Palen et al. (1995); 
Melani et al. (2004); Khassawneh et al. (2008) 
 
For Ellipta the device is loaded when opening the device, therefore one step was elimi-
nated for this inhaler. For this inhaler it is however very important that the air vents on 
the device are not blocked. Therefore an additional error to be measured was added (see 
Table 10). 
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Table 10: The instructions column describes the instructions given in the educational video for 
Ellipta. The second column describes the inhaler errors measured for Ellipta in this study. 
Inhaler Instructions Errors measured 
Ellipta  1. Wait to open the cover until you are 
ready to take your dose. Do not 
shake the inhaler 
2. Slide the cover down to expose the 
mouthpiece. You should hear a 
click. 
3. Breathe out away from the device 
for as long as you feel comfortable. 
Hold the inhaler away from your 
mouth - do not breathe out into the 
mouthpiece. 
4. Put the mouthpiece between your 
lips, and close your lips firmly 
around it. Do not block the air vent 
with your fingers.  
5. Take one long, steady, deep breath 
in through your mouth.  
6. Hold your breath for at least 3-4 
seconds 
7.  Remove the inhaler from your 
mouth.  Breathe out slowly and 
gently. 
8. Slide the cover upwards as far as it 
will go, to cover the mouthpiece. 
1. Failure to open/load device 
2. Failure to hold device in right po-
sition 
3. Failure to emptying lungs before 
inhalation 
4. Failure to hold breath at least 3-4 
seconds after inhalation 
5. Holding fingers on air vents 
6. Exhalation into the mouth piece 
Source: Price et al. (2012); Association of Finnish Pharmacies (2015); van der Palen et al. (1995); 
Melani et al. (2004); Khassawneh et al. (2008) 
 
In addition to the errors measured, mentioned in Tables 7-10 there are other errors that 
may affect the inhaler efficacy. This mainly concerns not achieving a forceful enough 
inhalation. Since this was hard to measure based on observations only, it was excluded 
from this study. For readers it is however important to note that these factors also affect 
correct inhaler use. 
 
5.4.2 Scoring the preference of the participants 
 
Preference was assessed using a self-completed questionnaire containing both open and 
closed questions. After trying all four inhalers the participants were asked to rank the 
inhalers from 1-4, one being the best score and four being the worst. The distribution of 
the participants’ rankings were counted and presented. This was done by calculating how 
many percent of participants had chosen each inhaler as first, second third and fourth.  
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After this the average preference score for each inhaler was calculated. The average pref-
erence score represents the average score assigned to each inhaler (scale from 1 to 4) 
when observing the whole sample (n=31). The lower the average score, the more highly 
the inhaler was on average ranked by participants. The statistical significance of the dif-
ferences between the average preference-scores were assessed through running a paired 
samples t-test in Excel. 
 
In order to gain a deeper understanding of why an inhaler was preferred each participant 
was asked to motivate why they had chosen their scores for the inhalers. This qualitative 
information was themed into different categories and the results were used to make com-
parisons between the inhalers. These motivations were also used to explain, which char-
acteristics were deemed important by participants. 
 
In addition to the open question regarding preference, all participants were asked closed 
questions regarding inhaler properties such as size, ease of use and ability to carry the 
inhaler with you if necessary were evaluated using structured questions and a Likert scale 
ranking. The purpose of these questions was to enable comparisons between different 
characteristics of the inhaler. 
 
5.5 Statistical tests 
 
5.5.1 T-test 
 
In order to assess the significance of the obtained results from the study t-tests were per-
formed. As the participants using the different inhalers remained constant, a paired sam-
ples t-test was found to be most suitable.  
 
Shortly summarized the paired samples t-test tests for the probability that the observed 
difference between the means of two related samples can be explained by sampling error. 
The paired samples t-tests for frequency of error and preference scoring were calculated 
for each possible inhaler pairing. 
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The obtained p values from the t-tests were then observed in order to determine the sig-
nificance of the differences between the sample means. A p value of 0.05 was used in this 
study. The differences between inhalers regarding error frequency and preference were 
therefore deemed significant, if the calculated p value was equal to or less than 0.05. If 
the calculated value was higher than 0.05, it was assumed that there was no statistically 
significant difference between the inhalers. The paired samples t-tests were performed 
using Microsoft Excel 2013 (Maciocha 2012). 
 
 
6. Results and discussion 
 
6.1 Inhaler error frequency  
 
When observing the frequency of error amongst participants, it was found that only 41 
out of 124 inhaler performances, or 33 %, were completed without any mistakes that 
could compromise the efficacy of the inhaled medication. The results of this study are 
comparable to other studies of handling error frequency for asthma inhalers. The fre-
quency of error in other studies have varied based on inhaler types and study methodol-
ogy. Crompton et al. (2006) and Lavorini et al. (2008) found that error frequency could 
concern as much as 50-94 % of asthma patients depending on the inhaler used. 
 
The percentage of self-evaluated correct use and actual correct use varied greatly. The 
differences can be observed in Table 11. When examining the participants’ use of the 
inhalers, Ellipta proved to be the one that was most often used correctly. Out of the par-
ticipants 84 % thought they had used the inhaler without making any mistakes. The actual 
number of participants who were able to use the inhaler was 55 %. During self-evaluation 
for Diskus the same amount (84 %) reported that they had used the inhaler correctly. The 
actual amount who was able to use the inhaler without making any mistakes was 48 % of 
participants. 
 
Easyhaler was evidently perceived to be more difficult to use than the two previously 
mentioned inhalers. The number of participants who thought they had handled the inhaler 
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correctly was 74 % of participants. The number of participants who actually used the 
inhaler correctly was much lower than the results obtained through the self-evaluation. 
The percentage of participants, who were actually able to use Easyhaler without making 
any mistakes, was 19 %. 
 
Out of all four inhalers Turbuhaler was clearly perceived to be the hardest to use with 65 
% of participants stating that they had used the inhaler correctly. The actual number of 
participants who were able to use the inhaler correctly without making any mistakes was 
16 %. 
 
Table 11: The percentages for self-evaluated correct use and actual correct use for each inhaler 
type. 
Number of participants who believed they 
had used inhaled correctly  
Number of participants who actually used 
the inhaler correctly 
Diskus Easyhaler Ellipta 
Turbu-
haler 
Diskus Easyhaler Ellipta 
Turbu-
haler 
84 % 74 % 84 % 65 % 48% 19 % 55% 16 % 
 
When comparing the frequency of error for the different inhaler types, not all differences 
were deemed statistically significant. The difference between average frequency of error 
for Ellipta and Diskus was statistically insignificant (p = 0.103). So was the difference 
between Turbuhaler and Easyhaler (p = 0.655). When examining the average error fre-
quency for Ellipta in comparison to the Easyhaler and Turbuhaler the differences were 
statistically significant (p = 8.4 x 10-5 and p = 3.6 x 10-6). The average frequency of error 
was also deemed statistically significant between Diskus and Easyhaler as well as the 
Turbuhaler (p = 0.001 and p = 0.005). Table 12 shows the average frequency of error for 
each inhaler, as well as the p values from the paired samples t-tests. 
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Table 12: Average frequency of error for each inhaler and the p values from the paired samples 
t-tests. The average frequency of error represents the average number of mistakes made for each 
inhaler when observing the whole sample (n=31). P values equal to or less than 0.05 are indi-
cated by *.  
 
Easyhaler 
(1.42) 
Ellipta 
(0.52) 
Turbuhaler 
(1.32) 
Diskus 
(0.77) 
p=0.001* p=0.103 p=0.005* 
Easyhaler 
(1.42) 
- p=8.4 x 10-5 * p=0.655 
Ellipta 
(0.52) 
- - p=3.6 x 10-6* 
 
 
Based on the distinct difference between the participants’ self-assed frequency of error in 
comparison to the actual one, it is clear that participants often thought they were using 
the inhaler correctly when they in fact were making mistakes. This is consistent with 
research from other studies regarding inhaler technique of asthma patients, which have 
found that many patients might not be aware of the fact that they are using their inhalers 
incorrectly (Erickson et al. 1998; Hämmerlein et al. 2011). Furthermore, it has been found 
that asthma patients often overestimate their own abilities and inhaler technique (Erickson 
et al. 1998; Hämmerlein et al. 2011). Studies regarding asthma patients’ adherence to 
therapy have also shown that the self-reported adherence often is higher than the actual 
adherence to prescribed therapy (Bae et al. 2009). 
 
The phenomenon described above should be taken into careful consideration by prescrib-
ers and pharmacists when refilling prescriptions and dispensing inhaler medication to 
asthma patients. Many asthma patients may be under the impression that they have perfect 
inhaler technique and that they are not in the need of additional instructions. Based on 
this study, and further supported by others, patients may very well need help in correcting 
their inhalation technique as they may not be aware of their mistakes. 
 
Fink and Rubin (2005), among others, have suggested that inhalers represent technology 
that is considered to be so intuitive and easy to use that a large part of patients and pre-
scribers do not receive sufficient training. This type of attitude towards asthma inhalers 
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and inhaler education is supported by some documented comments from the participants 
in this study. A few participants declared that they could not understand how these inhal-
ers could be misused. This may have resulted in them paying less attention to the instruc-
tions given. After completing all four inhaler demonstrations and filling in all the ques-
tionnaires for the study a number of participants wanted to know, whether they had used 
the inhalers correctly. Many participants were shocked to learn that they had made mis-
takes. This supports the claim by Fink and Rubin (2005). The perception of inhalers as 
very intuitive and easy to use may lead to the importance of instructions being overlooked. 
 
Table 13 presents a short summary of the most common mistakes detected for each in-
haler type. The different types of inhaler errors and their frequency will be presented in 
further detail later on in this chapter. 
 
Table 13: A short summary of the most common mistakes for each inhaler. 
Inhalers Most common mistake * Second most common mistake * 
Diskus 
Insufficient emptying of the lungs be-
fore inhalation (42 %) 
Insufficient holding of breath (29 %)  
Easyhaler 
Insufficient emptying of the lungs be-
fore inhalation (65 %) 
Insufficient holding of breath (39 %) 
Ellipta 
Insufficient emptying of the lungs be-
fore inhalation (26 %) 
Insufficient holding of breath (23 %) 
Turbuhaler 
Insufficient emptying of the lungs be-
fore inhalation (48 %) / Failure to load 
the device (48 %) 
The inhaler is not held in the correct 
position (19 %)  
* Percentage of participants who made the mistakes 
 
6.2 Ease of use 
 
In the questionnaires participants were asked to evaluate ease of use for each inhaler. 
Results show that ease of use was rated highest for Ellipta, with 26 out of 31 participants 
strongly agreeing with the statement that the inhaler was easy to use. Diskus was per-
ceived as the second easiest to use with 17 out of 31 strongly agreeing with the statement. 
Easyhaler came in close to Diskus with 15 out 31 participants strongly agreeing that the 
inhaler was easy to use. Turbuhaler was perceived as the hardest to use with only 8 out 
of 31 participants strongly agreeing that the inhaler was easy to use. 
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The perception of ease of use in this study correlates well with the actual correct use 
observed among participants (see Table 11). As can be observed from the error frequen-
cies found in the previous section, Ellipta emerged as the most frequently correct used 
inhaler out of all the inhalers in this study. Thereafter came the Diskus, Easyhaler was 
third and most handling errors was displayed with the Turbuhaler. There was no statistical 
difference between Ellipta and Diskus. 
 
No other studies comparing the ease of use for Ellipta, Diskus, Easyhaler and Turbuhaler 
has been found. The order of easiest to hardest to use does, however, appear be to be 
supported by some studies. On the other hand, other studies contradict the findings of this 
study. One study assessing the competence of inhaler-naïve subjects in handling the El-
lipta in comparison to the Diskus and the Turbuhaler and found that an overwhelming 
majority of users were able to use the Ellipta correctly on their first attempt after reading 
the inhaler handling leaflet (Sharma et al. 2014). These findings are not fully supported 
by this study as only a very small majority was able to successfully perform the inhalation 
process for Ellipta on their first attempt. 
 
The results by Sharma et al. (2014) indicated that 38.2 % of users exhibited one or more 
mistakes when using Diskus for the first time. The participants of this study did, however, 
display a much higher incidence of errors using the Diskus with 62 % of participants 
making one or more mistakes. Sharma et al. (2014) found that 83 % of participants ex-
hibited one or more mistakes upon inhalation when demonstrating the use of Turbuhaler 
for the first time. The frequency of for the Turbuhaler in this study was 87.1 %. There are 
some variations between the percentages of error frequencies of the study conducted by 
Sharma et al. (2014) and the results of this study. The order of easiest to use, to hardest 
to use is, however, consistent with the findings of this study. 
  
Results by Clay (1994) also seem to support some of the findings of this study. Clay 
(1994) found that 74 % of patients were able to use the Diskus correctly after a single 
demonstration in comparison with just 32 % of patients who were able to use the Tur-
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buhaler (Clay 1994). The fact that the Diskus is more often used correctly than the Tur-
buhaler is supported by the findings of this study. Clinical studies tend to exclude patients 
who exhibit suboptimal inhaler technique (Haughney et al. 2010). This may create a dis-
torted perception of inhaler use and handling errors patients face in everyday life. The 
frequencies of correct inhaler technique for both Diskus and Turbuhaler appeared to be 
much higher in the study by Clay (1994) in comparison with results from this study. The 
findings that the Diskus appeared to be easier to use correctly than the Turbuhaler is, 
however, supported by the results of this study.  
 
Not all previous research is in line with the findings of this study. A randomized multi-
center parallel group trial compared correct use and acceptability of Diskus, Turbuhaler, 
and Easyhaler among 326 inhaler naive asthmatics/symptomatics (Rönmark et al. 2005). 
The differences between the inhalers in Rönmark’s study were not significant. In this 
study, the difference in frequency of error was not significant between Easyhaler and 
Turbuhaler. The frequency of error for both inhalers in comparison to Diskus, was how-
ever significant.  
 
After receiving the first demonstration in the trial by Rönmark et al. (2005) the following 
proportion of subjects were able to use the device correctly: Turbuhaler, 51 %, Easyhaler, 
45 %; Diskus, 43 %.  During the end of the four week trial, during which additional train-
ing was given, the corresponding figures were 89 % for the Diskus, 84 % for the Easyhaler 
and 81% for the Turbuhaler. Ellipta had not yet been launched at the time of which the 
study was conducted.  The difference between the results of this study in comparison with 
Rönmark et al. (2005) is rather surprising. Much like this study, Rönmark et al. used 
inhaler naïve individuals and a validated scoring method using videotaped demonstrations 
of the inhaler performances. The most significant difference between the studies is the 
use of the product leaflet as an educational method. It is unclear whether the leaflet could 
be read during the actual inhalation demonstration. This may have promoted better recall 
of the process and led to lower error frequencies than those observed in this study. The 
leaflet for Easyhaler was reported to be easier to understand than those for Diskus and 
Turbuhaler (Rönmark et al. 2005). This may have led to better results for Easyhaler, than 
those observed in this study. Some difference in the difficulty to understand the video 
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instructions provided in this study were also reported. The videos for Ellipta and 
Easyhaler were often described as two fast to follow. This may have given these two 
inhalers in an unfair disadvantage. 
 
The participants of this study were all young adults and a majority had an academic edu-
cation. Higher educational level has been shown to significantly correlate with scores of 
correct handling of inhaler devices (Molimard et al. 2003). Furthermore it has been sug-
gested that older people may find it difficult to operate inhalers as poor manual dexterity, 
weakness, and visual limitations present potential problems affecting inhaler use amongst 
elderly (Jarvis et al. 2007).The participants of this study should therefore, at least in the-
ory, find it easier to learn how to use the inhalers correctly than many asthma and COPD 
in the real world. This may be considered alarming as the frequency of error was high (67 
%) in the sample population of this study. 
 
6.3 Defining the most common inhaler errors 
 
When analyzing the videos of the participants’ inhaler technique some patterns regarding 
the errors made started emerging. Table 14 lists the inhaler handling errors deemed criti-
cal for the inhaler to work properly, and the frequency of the mistakes for each inhaler. 
In addition to these errors the inspiratory flow rate of the inhalation is deemed a critical 
step in order for the used DPIs to work properly. Due to the fact that no meter of inspira-
tory flow rate was available for this study, this critical error was left out. It is, however, 
important to point out that frequency of error may have been higher, had the strength of 
the participants inhalations been measured. 
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Table 14: Most common mistakes made by participants of this study (n=31). Error frequency 
expressed in percentage within parentheses. 
Error 
Diskus 
 
Easy-
haler 
Ellipta 
Turbu-
haler 
The inhaler is not held in the correct position 0 2 (6.5 %) 0 6 (19 %) 
Insufficient emptying of the lungs before inha-
lation 
13 (42 %) 20 (65 %) 8 (26 %) 15 (48 %) 
Insufficient holding of breath 9 (29 %) 12 (39 %) 7 (23 %) - 
Breathing out through mouth after inhalation 
(Turbuhaler only) 
- - - 2 (6.5 %) 
Exhalation into the mouth piece 2 (6.5 %) 0 0 0 
Holding fingers on air vents 
(Ellipta only) 
- - 0 - 
Loading the device 1 (3 %) 7 (23 %) 0 15 (48 %) 
Failure to open device 0 0 0 0 
n = number of participants.  
 
 
As observed in Table 14, the most frequent mistakes made by participants were related 
to the breathing technique that should have been used during inhalation. When analyzing 
the videos, insufficient emptying of the lungs emerged as the most frequently made mis-
take for all four inhalers. These results are consistent with the results from a literature 
review carried out by Lavorini et al. (2008), which indicated that the most frequently 
observed error was failure to exhale before inhaling through their DPI device; this error 
was made by 12–77 % participants depending on the inhalers used and with results vary-
ing between different studies. 
 
The second most common mistake observed in this study was insufficient holding of 
breath after the inhalation. This too was consistent with the results by Lavorini et al. 
(2008). The breathing technique required for Turbuhaler differs slightly from the breath-
ing technique for the other three inhalers in this study. For Diskus, Easyhaler and Ellipta 
the participants are required to hold their breath for 3-10 seconds depending on the in-
haler. For the Turbuhaler no holding of breath is required, instead the participants were 
asked to breathe out slowly through their nose after completing the inhalation. As seen in 
Table 14, much fewer mistakes were made for the post inhalation breathing technique for 
Turbuhaler than for the other three inhalers. 
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Other errors commonly found in previous research included incorrect positioning of the 
inhaler, incorrect rotation sequence during loading, and failure to execute a forceful and 
deep enough inhalation (Lavorini et al. 2008). The results from previous studies appear 
to be consistent with the findings of this study. 
 
6.4 Preference  
 
After trying all four inhalers the participants were asked to rank the inhalers from 1-4, 
one being the best score and four being the worst. Table 15 shows the distribution of the 
participants’ preferences and how often each inhaler was ranked first, second, third and 
fourth.  
 
Table 15: Distribution of the participants’ inhaler rankings. 
Ranking Diskus Easyhaler Ellipta Turbuhaler 
1st 9.7 % (3/31) 12.9 % (4/31) 51.6 % (16/31) 25.8 %  (8/31) 
2nd 45.1 % (14/31) 19.4 % (6/31) 9.7 % (3/31) 25.8 % (8/31) 
3rd 22.6 % (7/31) 25.8 % (8/31) 25.8 % (8/31) 25.8 % (8/31) 
4th 22.6 % (7/31) 41.9 % (13/31) 12.9 % (4/31) 22.6 %  (7/31) 
 
The final rankings, based on the calculated average score given to each inhaler, can be 
observed in Table 16. The lower the average score, the more highly the inhaler was ranked 
by participants. The average score was obtained by adding the scores given for each in-
haler type and dividing the results by the number of participants. The average preference 
scores were compared to each other using a paired sample t-test. The results from the t-
test can be observed in table 17.  
 
Table 16: The order of preference of the inhalation devices.  
Ranking Inhaler Average score 
1st Ellipta 2.0 
2nd Turbuhaler 2.5 
3rd Diskus 2.6 
4th Easyhaler 3.0 
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Ellipta received the lowest average score and was thereby found to be most preferred by 
participants (see table 16). Ellipta was also chosen as a favorite by most participants with 
51.6 % (16/31) of participants stating that Ellipta was their favorite out of the four inhal-
ers.  Turbuhaler was the second most preferred inhaler based on the average score. As 
observed in Table 15 the distribution of preference in the four categories was most even 
for Turbuhaler with the inhaler receiving almost equal distribution in all categories. 
 
Diskus came in third when measuring the participants’ average score. The inhaler was, 
however, chosen as a favorite the fewest times. As seen in Table 15, only 9.7 % (3/31) 
chose the inhaler as their favorite. The reason for Diskus receiving a more preferable 
average score than Easyhaler comes down to the fact that the largest percentage of par-
ticipants scored it as their second most preferred inhaler. In fact 45.1 % (14/31) of partic-
ipants chose the inhaler as their second most preferred device. 
 
Based on the average score Easyhaler was the least preferred inhaler amongst the partic-
ipants of this study. The inhaler was also the one that was chosen to be the least favorite 
by the largest number of participants. Thirteen out of 31 participants, or 41.9 %, stated 
that the inhaler was their least preferred out of the four. The inhaler was chosen as a 
favorite by 12.9 % (4/31) of participants. This is more than the number of individuals 
who declared Diskus to be their favorite. 
 
When comparing the average preference scores, only the difference between the inhaler 
that received the highest score (Ellipta) and the inhaler that received the lowest score 
(Easyhaler) was deemed statistically significant (p=0.010). Table 17 presents the p values 
for each inhaler combination when comparing their average preference scores.  
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Table 17: The table shows the average preference score for each inhaler, as well as the p values 
from paired samples t-tests. P values equal to or less than 0.05 are indicated by *.  
 
Easyhaler 
(3.0) 
Ellipta 
(2.0) 
Turbuhaler 
(2.5) 
Diskus 
(2.6) 
p=0.178 p=0.059 p=0.690 
Easyhaler 
(3.0) 
- p=0.010* p=0.111 
Ellipta 
(2.0) 
- - p=0.186 
  
The most frequently occurring answer for why Ellipta had been ranked high was the fact 
that it was easy to use, had few steps and that it was easy to get a grip of and hold correctly. 
Many participants (6/31) did, however, note that the inhaler looked somewhat boring and 
some suggested including color to brighten up the device and make it more fun and ap-
proachable. Even some (3/32) who ranked Ellipta first in the preference category criti-
cized the design for being boring or colorless and, as one participant put it, “not suitable 
for young people”. Overall 14/31 participants made comments that could be classified as 
negative, or slightly negative regarding the look and size of Ellipta.   Others (8/31) liked 
the modest design of the inhaler stating that is was neutral and suitable for a medicine.   
 
Turbuhaler received the second best average preference score and received high praises 
for its size. Many people mentioned that it would be easy to carry around and the design 
of the device was liked by many participants. The fact that no holding of breath was re-
quired after inhalation was also mentioned as a positive aspect of the inhaler. The device 
was perceived as hard to use by many participants. This was repeatedly mentioned as a 
negative aspect. It was also commented that the text on the dose counter was written with 
very small print, and that it would be hard to keep track of the doses, if the inhaler was 
used in real life. 
  
The Diskus was, like Ellipta, perceived to be easy to use by participants. Those who gave 
it a high ranking mentioned that because the inhaler had only a few steps to complete 
during the inhalation process it was easy to operate. The design of the Diskus was, by 
many, considered modern and appealing. The negative comments of those who rated 
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Diskus with a low ranking were related to the design of the inhaler and the size, which 
many thought would make it harder to carry the inhaler around.   
  
The least preferred inhaler was the Easyhaler. The size of the inhaler was by many (12/31) 
considered to be a big plus and several participants stated that the inhaler would be easy 
to carry around. Participants stated that the inhaler had many steps that were to be com-
pleted before the inhaler was ready to use. This gave participants the perception of 
Easyhaler being complicated to use. This appeared to be one of the most often recurring 
motivations as to why the inhaler was given a low ranking. 
 
No other preference studies comparing all four inhalers were found during the literature 
review. Comparisons between some of the inhalers were, however, found. In a preference 
study van der Palen et al. (1998) found that the Turbuhaler was preferred over the Diskus 
regarding factors related to size and the number of available dosages. The dose counter 
of the Diskus was preferred over the Turbuhalers. These results appear to be in line with 
the findings of this study which also show a preference for the Turbuhaler over the 
Diskus. In accordance with the results by van der Palen et al. (1998) the size of Turbuhaler 
appeared to be preferred over the size of Diskus. 
 
A qualitative interview based study measuring patient satisfaction and preference among 
asthma and COPD patients for Diskus and Ellipta found Ellipta to be more often preferred 
than Diskus (Svedsatser et al. 2013) The fact that Ellipta was preferred over the Diskus 
seems to be supported by the findings of this study. The studies by van der Palen et al. 
(1998) and Svedsatser et al. (2013) were both sponsored by GSK.  
 
Some research contradicting the findings of this study was also found. A patient prefer-
ence study judging patient satisfaction for the Turbuhaler, Diskus/Accuhaler and the 
Easyhaler, found the Easyhaler to be the most satisfactory for patients (Giner 2004). 
When looking at these results it is important to note that all participants were asthmatics. 
Due to their existing asthma the patients had habitually used inhaled corticosteroids. Pre-
vious experience of inhalers may have created a bias towards some devices, or in other 
impacted the results of the study.  
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Researchers have proposed that patients who use their preferred inhaler might obtain a 
greater degree of satisfaction with therapy (Anderson 2015). If this were true, it would be 
an important advantage for both patients and caregivers with regards to the patient’s ther-
apy and achieving adherence. Based on the results of this study it is hard to argue a posi-
tion on this claim. On one hand the inhaler that was most often chosen as a favorite 
amongst the participants also emerged as the easiest one to use, and fewer mistakes might 
in fact lead to greater adherence to therapy. It is possible that this is merely a coincidence 
and of no significance. On the other hand the second most preferred inhaler turned out to 
be the one that the participants’ most often used incorrectly. In a real life situation if the 
inhalers were actually used incorrectly, this could lead to negative effects on the patient’s 
therapy. 
 
6.5 Overview of the results for each inhaler 
 
6.5.1 Turbuhaler 
 
Turbuhaler emerged as the second most preferred inhaler when participants were asked 
to rank the inhalers according to preference. The inhaler received the highest scores for 
suitable size and out of all four inhalers the largest amount of participants stated that they 
strongly agreed with the claim that the inhaler would be easy to carry around if needed. 
The design of the device also seemed to be appealing to most of the participants and the 
white and red color combination also received compliments. Furthermore 18 out of 31 
participants declared that they strongly agreed with the statement that the inhaler was easy 
to hold in the hands during inhalation (see Table 18). 
 
Despite of the fact that the inhaler received high preference and was widely liked by par-
ticipants, Turbuhaler proved to be the hardest inhaler to use with only 16 % managing to 
complete the inhalation without making any mistakes. This was reflected in the partici-
pants’ feedback on ease of use; only 9 out of 31 participants strongly agreed with the 
statement that the Turbuhaler had been easy to use. The distribution of the answers can 
be seen in Table 18. This is the lowest score for any of the inhalers present in this study. 
Almost half of the participants did however state that the different steps required for 
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achieving correct inhalation had been easy to memorize. This was more than for both 
Diskus and Easyhaler. 
 
The most common mistake among participants when demonstrating the use of Turbuhaler 
was not remembering to exhale before inhalation. Just as many as many participants failed 
to load the device properly. Some people who made mistakes during loading only turned 
the circle once instead of twice, others turned the circle too many times and some did not 
manage to turn until a click was heard. Even though the click is designed to act as a 
reinforcement for the patient, indicating that the dose has been loaded, many participants 
still managed to make mistakes in the process of loading the device. The fact that the click 
was supposed to act as a reinforcement indicating that the circle had been correctly 
loaded, was not noted by any of the participants of this study. 
 
Table 18: The distribution of answers to multiple choice questions regarding the properties of the 
inhaler. The response rate for the following questions was 100 %. n = 31. 
 
Strongly 
disagree 
Disagree 
Neither 
agree nor 
disagree 
Agree 
Strongly 
agree 
The inhaler was easy to hold 
during the inhalation 
1 1 0 11 18 
The inhaler was easy to use 1 1 3 17 9 
The different steps in the inha-
lation process were easy to re-
member 
0 5 2 9 15 
The size of the inhaler was 
suitable 
0 0 0 10 21 
The inhaler would be easy to 
carry around if needed 
0 0 0 7 24 
 
 
6.5.2 Easyhaler 
 
Despite Easyhaler receiving a low preference rank, many of its properties were ranked 
favorably. High remarks were given for the size of the inhaler with 19 out of 31 partici-
pants stating that they strongly agreed that the size of the inhaler was suitable (see table 
19). Furthermore, 21 out of 31 participants indicated that they strongly agreed with the 
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statement that the inhaler would be easy to carry around if needed. Only Turbuhaler re-
ceived higher remarks in these categories. See Table 19 for the full distribution of the 
participants’ answers for Easyhaler. 
 
Few comments (2/31) were made regarding the dose counter in the open questions. The 
participants who commented did, however, say that they thought the counter was very 
small and that the small print might have made it hard to read how many doses were left. 
The same types of comments were made for the dose counters of Turbuhaler and Diskus 
(3/31 and 1/31). 
 
When participants were asked what they thought of if the inhaler was easy to use, almost 
half of the participants stated that they strongly agreed with the claim. Yet, when demon-
strating the use of the inhaler only 19 % were able to complete the inhalation without 
making any mistakes. Just like with Diskus and Ellipta, the most frequently recurring 
inhalation errors were related to the breathing technique such as not exhaling before the 
inhalation and not holding their breath long enough after the inhalation. These errors 
were, however, more frequent in Easyhaler than in the two above mentioned inhalers. 
 
One of the factors that may contribute to the difficulties participants had using the 
Easyhaler is the many steps required in the inhalation process. Some participants stated 
that the large number of steps made it harder to remember all the things that needed to be 
done. The number of participants who thought the different inhalation steps were easy to 
remember were, however, slightly higher than those for Diskus, which had fewer steps to 
memorize. 
 
When participants were asked to indicate preference, the Easyhaler emerged as the least 
preferred inhaler. Many participants stated that the inhaler had too many steps to complete 
before the inhaler was ready to use, this made it complicated. This factor appeared to be 
one of the most often recurring motivations for giving the inhaler a low ranking. 
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Table 19: The distribution of answers to multiple choice questions regarding the properties of the 
inhaler. The response rate for the following questions was 100 %. n=31. 
 
Strongly 
disagree 
Disagree 
Neither 
agree nor 
disagree 
Agree 
Strongly 
agree 
The inhaler was easy to hold 
during the inhalation 
0 1 3 10 17 
The inhaler was easy to use 1 4 3 8 15 
The different steps in the in-
halation process were easy to 
remember 
2 6 2 10 11 
The size of the inhaler was 
suitable 
0 1 3 8 19 
The inhaler would be easy to 
carry around if needed 
0 2 1 7 21 
 
6.5.3 Diskus 
 
Ease of use is an important characteristic of an inhaler. The results of this study showed 
that Diskus was the second easiest to use to use out of the inhalers studied. No significance 
between the average error frequency for Ellipta and Diskus was found. The average error 
frequency for Diskus in comparison to both Easyhaler and Turbuhaler was significantly 
lower. The inhaler required fewer steps for reconstitution than for example Easyhaler and 
Turbuhaler. The steps for Diskus were, however, more than those for Ellipta. According 
to previous studies on inhaler properties, an ideal inhaler should be ease to teach, as well 
as learn, how to use. When the participants were asked if they thought that Diskus had 
been easy to use, 17 out of 31 participants, or 55 %, strongly agreed with the statement. 
The distribution of the participants’ answers to this question among other questions can 
be seen in Table 20. 
 
Results of this study showed that 52 % of the participants failed to use the inhaler without 
making any mistakes when they were asked to demonstrate the use of it for the first time. 
Even though this is a good result in comparison with some of the other inhalers in this 
study there is still room for improvement. The most common mistake participants made 
when demonstrating how they would have used the Diskus was insufficient emptying of 
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the lungs before inhalation. The requirement for holding the breath for 5-10 seconds after 
the inhalation was another step that was often completed incorrectly amongst the partici-
pants’ of this study. 
 
Even though the Diskus had fewer steps in its inhalation process than Easyhaler and Tur-
buhaler, fewer participants stated that they strongly agreed with the statement that the 
steps in the inhalation process were easy to remember. This is an interesting phenomenon. 
No indications as to why participants thought so could be found from the structured in-
terview or the comments of the participants that were written down. 
 
Melani (2007) states that an ideal inhaler should be pocket sized, light weighed and easy 
to carry around. When participants of this study were asked whether they thought the size 
of the inhaler was suitable only 8 out of 31 participants stated that they strongly agreed 
with the argument. When asked if the inhaler would be easy to carry around, if needed, 
merely 6 participants stated that they strongly agreed with the claim. The satisfaction with 
regards to size was the lowest for all inhalers in this study and much lower than that for 
Easyhaler and Turbuhaler which are smaller in size. Even though the size did not please 
the participants of this study, Diskus was still, by many, considered to be the best looking 
out of all of the inhalers. 
 
Only one participant commented on the dose counter of the Diskus, and this individual 
thought the small print in which it was stated made it hard to follow the remaining doses. 
When participants were asked whether it was easy to hold the Diskus in their hand during 
the inhalation just under half of the participants strongly agreed to the claim. The Diskus 
is loaded when the lever on the device is pushed down. This acts as a feedback mechanism 
for the patient, indicating that the dose has been loaded correctly. The feedback mecha-
nism was not commented on by participants. 
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Table 20: The distribution of answers to multiple choice questions regarding the properties of the 
inhaler. The response rate for the following questions was 100 %. n= 31. 
 
Strongly 
disagree 
Disagree 
Neither 
agree nor 
disagree 
Agree 
Strongly 
agree 
The inhaler was easy to hold 
during the inhalation 
0 1 0 15 15 
The inhaler was easy to use 0 2 4 8 17 
The different steps in the in-
halation process were easy to 
remember 
0 3 5 13 10 
The size of the inhaler was 
suitable 
0 3 10 9 8 
The inhaler would be easy to 
carry around if needed 
0 5 6 14 6 
 
6.5.4 Ellipta 
 
Based on the results of this study, Ellipta was the inhaler that was most frequently used 
correctly with 55% of participants’ completing the inhalation without making any mis-
takes. Based on the participants’ answers regarding ease of use, the inhaler was also the 
one that was perceived to be the easiest to use out of all the four inhalers with 26 out of 
31 participants strongly agreeing with the statement that the inhaler had been easy to use.  
Even though a very small majority learned how to use the inhaler properly on the first try, 
there were still almost as many participants who made at least one mistake when demon-
strating the use of the Ellipta. 
 
All of the mistakes participants made using the Ellipta were related to breathing tech-
nique. In the light of this information it is important to highlight these steps when teaching 
patients how to use the inhaler. The few number of steps needed to be completed during 
the inhalation process does seem to indicate that it makes it easier than some of the other 
inhalers to learn how to use, and this aspect may also make it easier to teach how to use. 
Ellipta was the inhaler for which participants stated that it had been easiest to remember 
all of the steps during the inhalation. The ergonomics of the inhaler were also appreciated 
and a clear majority of the participants (21/31) stated that they strongly agreed with the 
statement that the inhaler was easy to hold in the hand during the inhalation. 
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Ellipta also emerged as the inhaler that was most often chosen as the favorite out of the 
four inhalers with 51.6 % of participants ranking it as their favorite. Despite of this Ellipta 
received frequent critique for its design and size by many of the participants in this study. 
Only nine out of 31 participants strongly agreed with the statements that size of the inhaler 
was suitable, and that it would be easy to carry around if needed. The exact distribution 
of answers can be seen in Table 21. The design of the inhaler was by many considered to 
be colorless and dull. Some did, however, state that the dull look did not matter because 
the purpose of the inhaler was not to look good, but to act as a medicine. 
 
The dose counter received compliments for being very clear and visually easy to under-
stand. When the cover of Ellipta is slid open there is a clicking sound that acts as rein-
forcement that the dose has been loaded correctly, this was, however, not commented on 
by any of the participants. 
 
Table 21: The distribution of answers to multiple choice questions regarding the properties of the 
inhaler. The response rate for the following questions was 100 %. n = 31. 
 
Strongly 
disagree 
Disagree 
Neither 
agree nor 
disagree 
Agree 
Strongly 
agree 
The inhaler was easy to hold 
during the inhalation 
0 0 1 9 21 
The inhaler was easy to use 0 1 1 3 26 
The different steps in the in-
halation process were easy to 
remember 
1 2 0 5 23 
The size of the inhaler was 
suitable 
0 3 4 15 9 
The inhaler would be easy to 
carry around if needed 
0 6 2 14 9 
 
 
 
69 
 
 
6.6 Inhaler education and instructions 
 
It has been claimed that patient education is a factor that plays one of the most important 
roles in the patients’ use and misuse of asthma inhalers (Fink & Rubin 2005). Many stud-
ies regarding the efficiency of different training methods have been made to evaluate 
which one is optimal for achieving correct inhaler technique. There are several different 
approaches available for training in inhaler technique. In this study video instructions 
were used to give the participants standardized instructions on how to use the inhaler 
present in this study. 
 
The participants of this were asked what kind of education they would have needed in 
order to properly learn how to use the inhalers present for this study. Many participants 
thought that a video was a good way of giving instructions for how to use an asthma 
inhaler. When asked what the instructions should be like, participants stated that they 
should be clear and simple steps that showed how the inhaler should be loaded, inhaled 
and the breathing technique that should be used. The videos used for the purpose of this 
study all contained the above mentioned steps. 
 
Recurring feedback from participants for all of the videos was that they were so fast that 
the information didn’t really have time to sink in. The educational video for Ellipta re-
ceived the most negative comments with many participants stating that the tempo was too 
fast to follow the instructions properly. The distribution regarding the participants’ state-
ment of how easy the steps of the education were to understand can be found in Appendix 
4. Some suggested that combining the video education with written instructions, or a 
checklist of the different steps, might have been a good reminder of how to use the inhaler. 
 
Many participants (5/31) commented that they thought a video was a better way of teach-
ing the use of an inhaler than just providing them with a written manual. The perception 
that a manual might not be enough if the object is to learn how to use the device is sup-
ported by previous research. A study by Roberts et al. (1982) suggested that provision of 
the manufacturer’s instruction sheet alone was ineffective, partially due to the fact that 
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patients tended to overlook the information in it. Other studies have shown written in-
structions in the form of a leaflet to be inefficient, even for those patients who actually 
read the leaflet (Melani et al. 2004). Nimmo et al. (1993) as seen in Rönmark et al. (2005) 
found that only 6 % of participants in their study demonstrated a correct technique with 
Turbuhaler the first time after receiving written instructions on how to use the device. 
 
In this study 67 % of the videotaped inhaler demonstrations by participants were done 
with the participants making at least one critical error. As a majority made mistakes when 
first demonstrating the use of the inhalers it could be argued that video instructions alone 
might not be enough when teaching patients how to use an asthma inhaler. The results 
may also be indicating that there is considerable room for improvement in video instruc-
tions for the purpose of teaching asthma patients to learn how to use the inhalers. 
 
When the participants were asked what kind of education they would have needed in 
order to properly learn how to use the inhalers, a frequently recurring comment for each 
inhaler was that the participants’ felt they needed feedback on their own performance. 
Participants often mentioned that a personal one on one meeting would have allowed 
them to clear up unclear issues and questions that may have arisen during the demonstra-
tion. Participants also seemed to have questions regarding the different steps presented in 
the videos. Questions people tried to ask included “why should I shake the inhaler” and 
“why shouldn’t I shake the others inhaler?” etc. There were also many misconceptions 
regarding the inhalers. One participant explained that the instructions on how to adjust 
the dosage had been very unclear. In reality none of the inhalers asthma doses can be 
adjusted. During the videos this participant had been under the impression that the size of 
a dose of the medication could be adjusted by the patient themselves. 
 
The questions that arise may vary greatly between different individuals. That was appar-
ent in this study even though the participants all received identical instructions. In order 
for inhaler users to get an achieve correct inhaler technique it would be important that 
these individuals would have the opportunity to ask questions, get feedback and have 
someone correct the mistakes that were made. As it has been presented in the section 
“Inhaler error frequency” a significant number of participants believed that they had 
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learned how to use the inhaler correctly even though the results from the scored video 
demonstrations showed that mistakes had actually been made. One on one education with 
feedback on inhaler technique support the patients’ treatment, by making them aware of 
their mistakes, and thereby giving them clear guidelines on what to improve on. 
 
The participants’ perception that one on one interactive sessions would have been a better 
way of making sure that they actually learned how to use the inhalers is backed up by 
previous studies. Van der Palen et al. (1997), among others, have found that individual 
and small group demonstrations of interactive nature be the most effective alternatives 
for providing inhaler education. Furthermore research has shown that periodic retraining 
is needed as inhaler technique declines over time. Inhaler handling must be repeated reg-
ularly in order to achieve and maintain the correct technique (Takemura et al. 2010; O'Bey 
et al. 1982). 
 
Some who said that they would prefer a one on one instruction with feedback provided 
on their performance stated that they thought the video instructions would act as great 
reminders of how to use the inhaler. The idea of using videos was mentioned by two 
separate individuals on several different occasions. This perception is supported by pre-
vious research. Research by Wilson et al. (2010) among others indicates that the use of 
video and print interventions can promote recall on inhaler use in asthma patients. 
 
Previous studies have shown that health care professionals play an important role in the 
achieving correct inhaler technique and maintaining it over time (Takemura et al. 2010). 
Many health care professionals, however, display some difficulties when asked to demon-
strate the correct technique for asthma inhalers and according to Fink & Rubin (2005) 
between 39–67 % of nurses, respiratory therapists and doctors are unable to sufficiently 
describe, or perform, critical steps for inhaler use. Because of this, it was hypothesized 
that videos would be a good form of providing easily accessible standardized form of 
providing correct training for asthma patients. 
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The video instructions used for this study were very basic, non-interactive, instruction 
videos describing each step that the participants were to perform during inhalation. Re-
search on the subject of instructional videos in e-learning have established that students 
who were provided interactive educational videos achieved significantly better learning 
performance and a higher level of learner satisfaction than those who were provided a 
non-interactive video, or no video at all (Zhang et al. 2006). These findings indicated that 
it may be important to integrate interactive instructional video into e-learning systems 
(Zhang et al. 2006). If video instructions were to be more widely used as a method of 
providing instructions to asthma patients it would be interesting to look into the possibil-
ity of developing interactive videos for this purpose.  
 
Future research should look into if these types of videos would be suitable for giving 
inhaler education to patients, and how different types of interactive videos could assist in 
the goal of achieving and maintaining correct inhaler technique.  
 
6.7 Limitations of the study 
 
The first limitation that arose during the data collection process was the fact that the in-
struction video for Easyhaler included a protective cover which the inhaler could be 
placed in during the inhalation process and afterwards for protection from environmental 
factors. When the demonstrational placebo inhalers were ordered from Orion, the protec-
tive cases were not included in the delivery and therefore these covers were not accessed 
during the data collection process. All demonstrational inhalers were ordered through the 
same process that any other health care professionals would have ordered those inhalers. 
As such the situation simulates the reality many patients face when receiving instructions 
from health care professionals. Measures were taken to minimize the harm caused by this 
discrepancy as much as possible. 
All participants were informed that the video would feature an “extra” cover for the in-
haler, and the participants were told to disregard it. The fact that the participants were not 
able to fully follow the instructions of the video may have harmed their perception of the 
Easyhaler and its ease of use. The absence of the protective cover did, however, remove 
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an additional step in the inhaler handling process and it reduced the participants’ percep-
tion of the inhaler size. These are again factors that based on the general comments of the 
participants were considered to be positive, and thereby they may have benefited the par-
ticipants’ perception of the Easyhaler. 
Another possible limitation of this study lies in the educational distribution of the sample 
of this study. A clear majority of participants (23/31) were from an academic background. 
Previous research has shown that educational level significantly correlated with scores of 
correct handling of inhaler devices (Molimard et al. 2003). This may have influenced the 
results of this study. The sample size was too small to find any relationship between ed-
ucational background and inhaler control. If the results were affected by the educational 
background one can assume that it would have affected the inhaler handling for all of the 
inhalers in this study, therefore, it should not have distorted the results of this study by 
creating a bias towards any inhaler in particular. 
The final area that could possibly arise as a limitation of this study is the fact that the 
design of this study required participants to use all four inhalers right after one another. 
Previous research has shown that patients who used several different inhalers are at a 
higher risk of getting confused with the instructions and they usually require more time 
to learn how to use their devices correctly (Melani 2007). 
 Due to the fact that all the participants were inhaler naïve, and the steps for the DPIs 
used share some similarities, it was considered very likely that the subjects would actu-
ally learn how to use DPIs better later in the process. In this case the inhaler that was 
tried first would be at the greatest disadvantage. As the participant would watch the other 
videos and repeat the other process it was hypothesized that the participants’ would learn 
to use DPIs better along the way due to the similar steps shared by the inhalers. The order 
of the inhaler performances was randomized by lottery in order to remove a bias towards 
any inhaler in particular. For the purpose of this study, it was important that the inhalers 
could be compared against each other. The benefits and disadvantages were weighed 
against each other and it was determined that the chosen method was the best way to go. 
In the end it was considered that the risks for bias were equally high for each inhaler due 
to the fact that the order was determined by lottery. 
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7. Conclusions 
 
This study aimed to address how easily an individual with no inhaler experience can learn 
how to use an asthma inhaler through video education. The different properties affecting 
ease of use were also investigated. The results show that the overall frequency of error 
for participants’ inhaler demonstrations was high. Out of 124 inhaler demonstrations, 67 
% were completed with the participants displaying at least one mistake. The error fre-
quency varied greatly between the inhalers. Based on the results, it could be proposed 
that it is rather difficult for individuals with no prior inhaler experience to learn how to 
use an asthma inhaler solely through video education. The level of difficulty varied be-
tween the inhalers and some proved to be either harder to use, or harder to teach through 
video instructions alone.  
 
When participants were asked to evaluate their own inhaler technique it became clear that 
a large number of participants strongly overestimated their own performance. This phe-
nomenon could be observed for all four inhalers. These results highlight the importance 
of providing feedback on inhaler use in order to assure that correct inhaler technique is 
achieved.  
 
Few logical steps that were easy to memorize seemed to be something that participants 
most often associated with ease of use. The inhalers that required the fewest steps (Diskus 
and Ellipta) were also more often used correctly. The participants’ own perception of 
which inhalers were easy, and which were hard, seemed to correlate fairly well with the 
actual results for correct use. In self-evaluation, participants most often perceived they 
had used Ellipta and Diskus correctly. These were also the two inhalers for which partic-
ipants displayed the fewest amount of errors during handling.  
 
When patients were asked to indicate preference, Ellipta emerged as the most frequently 
preferred inhaler followed by Turbuhaler. Those who preferred Ellipta seemed to value 
its ease of use, whereas those who gave the highest rank to Turbuhaler appreciated the 
design, as well as the size, of the inhaler. Diskus came in third and Easyhaler was the 
least preferred inhaler. For Easyhaler, many stated that the inhaler had too many steps to 
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complete before the inhaler was ready to use, this made it complicated. This factor was 
one of the most often recurring motivations for giving the inhaler a low ranking. Overall 
the preference rankings for each inhaler were quite close to one another. This is illustrated 
by the fact that only the difference between preference scores for Ellipta (most preferred) 
and Easyhaler (least preferred) was deemed statistically significant. 
 
After evaluating the properties of all four inhalers, as well as the preferences of the par-
ticipants of this study, it is fair to conclude that there still is no such thing as an ideal 
inhaler that would be suitable and liked by everyone. The differences in needs and pref-
erences require careful weighing when prescribers choose a new inhaler for a patient. The 
significant difference in error frequency for the oldest inhaler (Turbuhaler) and the newest 
one (Ellipta) can been seen as an indication that inhalers have developed to be more intu-
itive and easier to use in the last 25 years. As many participants still made mistakes for 
all inhalers used in this study, it may be fair to conclude that none of the inhalers are easy 
and intuitive enough to use without careful inhaler education and clear instructions. Pa-
tient education plays a central role in asthma care and needs to be given proper attention 
even though the inhalers might be considered intuitive and easy to operate. 
 
Finally, the goal of this study was to investigate educational videos as a method of provid-
ing inhaler education. According to the participants of this study, an educational video 
needs to explain all inhalation steps clearly in a slow enough pace. Only 33 % of the 
analyzed inhaler demonstrations were completed without any mistakes. Consequently it 
may be fair to conclude that video demonstrations are not an ideal way of providing in-
haler education for first time users of inhalers. The most prominent problem with video 
instructions is that it provides no feedback to the user regarding their inhaler technique. 
This may present real problems as the results of this study also show that people tend to 
overestimate their own technique. Another problem arises from the fact that the users are 
unable to ask questions and clear up misunderstandings. E-learning and video education 
could play a part in providing successful inhaler instructions in the future, but if so more 
interactive approaches providing patients with feedback should be developed. Future re-
search could therefore look into the use of interactive learning videos as a means of 
providing asthma patients with education on inhaler technique. 
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Appendix 1 
 
Täytä alla olevat kysymykset ennen kuin aloitat esittelyvideoiden katselua 
 
 Nainen    Mies 
 
Ikä ____ 
 
Asuinpaikkakunta: 
  Pääkaupunkiseutu (Helsinki, Espoo, Vantaa tai Kauniainen)   
 Muu:_____________________ 
  
Koulutustausta/ koulutusta jota parhaillaan suoritan 
 
  Yliopisto    Ammattikorkeakoulu  Ammattikoulu 
 
Minulla on astma 
  Kyllä    Ei 
  
Perheenjäseneni kärsii astmasta 
  Kyllä    Ei 
 
Minulla on aiempaa kokemusta astmainhalaattoreiden käytöstä 
  Kyllä    Ei 
 
Työskentelen/ olen työskennellyt apteekissa/lääketeollisuudessa 
 
  Kyllä    Ei 
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Appendix 2 
 
 Laite A   Laite B   Laite C              Laite D 
 Täysin eri 
mieltä 
Jokseenkin 
eri mieltä 
Ei samaa 
eikä eri 
mieltä 
Jokseenkin 
samaa mieltä 
Täysin sa-
maa mieltä 
Inhalaattori oli helppo pi-
tää kädessä käytön ai-
kana 
     
Inhalaattorin käyttö oli 
helppoa 
     
Käyttöohjeet koulutusvi-
deossa olivat selkeät 
     
Laitteen valmisteluvai-
heet oli helposti ym-
märrettäviä videokou-
lutuksessa 
     
Inhalaation eri valmiste-
luvaiheet oli helppo 
muistaa 
     
Inhalaattorin koko oli so-
piva 
     
Laite kulkisi helposti 
mukana tarvittaessa 
     
 
Mitä mieltä olet astmalaitteen ulkonäöstä? 
______________________________________________________________________
______________________________________________________________________
______________________________________________________________________
______________________________________________________________________
______________________________________________________________________
_____________________________________________________________________ 
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Millaista ohjeistusta tarvitsisit astmalaitteiden käytöstä? 
______________________________________________________________________
______________________________________________________________________
______________________________________________________________________
______________________________________________________________________
______________________________________________________________________
______________________________________________________________________
______________________________________________________________________
______________________________________________________________________
______________________________________________________________________
______________________________________________________________________
______________________________________________________________________
______________________________________________________________________
______________________________________________________________________
______________________________________________________________________ 
Mitä mieltä olit laitteen käytettävyydestä? 
______________________________________________________________________
______________________________________________________________________
______________________________________________________________________
______________________________________________________________________
______________________________________________________________________
______________________________________________________________________
______________________________________________________________________
______________________________________________________________________
______________________________________________________________________
______________________________________________________________________
______________________________________________________________________ 
 
Opitko videon perusteella käyttämään inhalaatiolaitetta? 
______________________________________________________________________
______________________________________________________________________
______________________________________________________________________
______________________________________________________________________
______________________________________________________________________
______________________________________________________________________
______________________________________________________________________
______________________________________________________________________
______________________________________________________________________ 
 
Miksi/Miksi et? 
______________________________________________________________________
______________________________________________________________________
______________________________________________________________________
______________________________________________________________________
______________________________________________________________________
______________________________________________________________________
______________________________________________________________________
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______________________________________________________________________
______________________________________________________________________ 
 
Vastaa viimeiseen kysymykseen vasta sitten kun olet käyttänyt kaikki neljä inha-
laattoria.  
Järjestele laiteet preferenssi järjestykseen yhdestä neljään. (1- pidin laitteesta eniten 2- 
pidin laitteesta toiseksi eniten, 3 – pidin laitteesta toiseksi vähiten, 4 – pidin laitteesta 
vähiten).  
____Laite A            ____ Laite B           ___ Laite C        ____ Laite D 
Perustele valintasi 
______________________________________________________________________
______________________________________________________________________
______________________________________________________________________
______________________________________________________________________
______________________________________________________________________
______________________________________________________________________ 
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Appendix 3 
Answers provided to the multiple choice questions for each inhaler to the multiple 
choice questions 
     
 
Diskus Täysin 
eri mieltä 
Jokseenkin 
eri mieltä 
Ei samaa 
eikä eri 
mieltä 
Jokseenkin 
samaa 
mieltä 
Täysin sa-
maa mieltä 
Inhalaattori oli 
helppo pitää kä-
dessä käytön ai-
kana 
0 1 0 15 15 
Inhalaattorin 
käyttö oli helppoa 
0 2 4 8 17 
Käyttöohjeet kou-
lutusvideossa oli-
vat selkeät 
0 1 1 12 17 
Laitteen valmiste-
luvaiheet oli hel-
posti ymmärrettä-
viä videokoulu-
tuksessa 
0 1 2 11 17 
Inhalaation eri 
valmisteluvaiheet 
oli helppo muistaa 
0 3 5 13 10 
Inhalaattorin koko 
oli sopiva 
0 3 10 9 8 
Laite kulkisi hel-
posti mukana tar-
vittaessa 
0 5 6 14 6 
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Easyhaler Täysin 
eri mieltä 
Jokseenkin 
eri mieltä 
Ei samaa 
eikä eri 
mieltä 
Jokseenkin 
samaa 
mieltä 
Täysin sa-
maa mieltä 
Inhalaattori oli 
helppo pitää kä-
dessä käytön ai-
kana 
0 1 3 10 17 
Inhalaattorin 
käyttö oli helppoa 
1 4 3 8 15 
Käyttöohjeet kou-
lutusvideossa oli-
vat selkeät 
1 2 3 13 12 
Laitteen valmiste-
luvaiheet oli hel-
posti ymmärrettä-
viä videokoulu-
tuksessa 
1 2 2 14 12 
Inhalaation eri 
valmisteluvaiheet 
oli helppo muistaa 
2 6 2 10 11 
Inhalaattorin koko 
oli sopiva 
0 1 3 8 19 
Laite kulkisi hel-
posti mukana tar-
vittaessa 
0 2 1 7 21 
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Ellipta Täysin 
eri mieltä 
Jokseenkin 
eri mieltä 
Ei samaa 
eikä eri 
mieltä 
Jokseenkin 
samaa 
mieltä 
Täysin sa-
maa mieltä 
Inhalaattori oli 
helppo pitää kä-
dessä käytön ai-
kana 
0 0 1 9 21 
Inhalaattorin 
käyttö oli helppoa 
0 1 1 3 26 
Käyttöohjeet kou-
lutusvideossa oli-
vat selkeät 
1 2 4 5 19 
Laitteen valmiste-
luvaiheet oli hel-
posti ymmärrettä-
viä videokoulu-
tuksessa 
0 2 2 2 25 
Inhalaation eri 
valmisteluvaiheet 
oli helppo muistaa 
1 2  5 23 
Inhalaattorin koko 
oli sopiva 
0 3 4 15 9 
Laite kulkisi hel-
posti mukana tar-
vittaessa 
0 6 2 14 9 
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Turbuhaler Täysin eri 
mieltä 
Jokseenkin 
eri mieltä 
Ei samaa 
eikä eri 
mieltä 
Jokseen-
kin samaa 
mieltä 
Täysin sa-
maa 
mieltä 
Inhalaattori oli 
helppo pitää kä-
dessä käytön aikana 
1 1 0 11 18 
Inhalaattorin käyttö 
oli helppoa 
1 1 3 17 9 
Käyttöohjeet koulu-
tusvideossa olivat 
selkeät 
0 2 3 13 13 
Laitteen valmistelu-
vaiheet oli helposti 
ymmärrettäviä vi-
deokoulutuksessa 
0 3 2 14 12 
Inhalaation eri val-
misteluvaiheet oli 
helppo muistaa 
0 5 2 9 15 
Inhalaattorin koko 
oli sopiva 
0 0 0 10 21 
Laite kulkisi hel-
posti mukana tarvit-
taessa 
0 0 0 7 24 
 
